Archives: InvestorWire

Nextech (CSE: NTAR) (OTCQX: NEXCF) (FSE: EP2), a metaverse company and leading provider of augmented reality (“AR”) experience technologies and 3D model services, today announced a patent update covering its breakthrough artificial intelligence (“AI”) technology 3D model creation. The company also reported that this proprietary AI-based 3D model creation using through composition of deformable parts is now covered under U.S. patent application number 17/874,992. “Today we are leveraging the game-changing power of generative AI, which we believe gives us a major competitive advantage in the 3D model market. With generative AI we are creating an increasingly wider exponentially growing moat: the more models we make, the larger that part library gets, and the easier it gets to make new 3D models,” said Evan Gappelberg, CEO of Nextech. “I believe that we are at the point where the value of Nextech goes up with each new 3D model we make, creating a virtuous cycle of growth and value. 2023 is going to be the year of AI. We have already announced multimillion-dollar enterprise contacts and more are expected in 2023. With our breakthrough AI that we are continuously developing, we are becoming the global go-to 3D model supplier for ecommerce. With hundreds of millions of 3D models needing to be made, we have been heavily investing in AI, which is now paying dividends. Our proprietary breakthrough AI perfectly positions us to take full advantage of the multibillion-dollar decade-long 3D model megatrend!”

To view the full press release, visit https://ibn.fm/yFIiA

About Nextech AR Solutions Corp.

Nextech is a diversified AR, AI technology company that leverages proprietary artificial intelligence (“AI”) to create 3D experiences for the metaverse. Its main businesses are creating 3D WebAR photorealistic models for the prime ecommerce marketplace as well as many other online retailers. The company develops or acquires what it believes are disruptive technologies and, once commercialized, spins them out as stand-alone public companies issuing a stock dividend to shareholders while retaining a significant ownership stake in the public spin-out. For more information about the company, visit www.NextechAR.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today provided a progress update on its sponsored research study with the University of California, San Francisco (“UCSF”). The study, which examines psilocybin’s effect on inflammatory activity in humans, evaluates three populations of patients suffering from Parkinson’s disease, bipolar and chronic pain. “The UCSF research team is making progress on the clinical trial. The data gathered from these studies could uncover the role of inflammatory activity on such conditions as Parkinson’s, bipolar disorder and chronic pain,” said Eric Weisblum, chief executive officer of Silo Pharma. “Utilizing psilocybin in this study in a regimented dosing pattern, we hope to gain significant data both in mechanism of action and potential biomarker for personalization of psilocybin therapy. The targeted patient populations from the study could provide support for the development and use of psilocybin as a therapeutic coupled with our novel homing peptides and topical technology.”

To view the full press release, visit https://ibn.fm/8sNNu

About Silo Pharma Inc.

Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which it believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CISO Global (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider formally known as Cerberus Sentinel, has signed a definitive agreement to acquire RAN Security, a cybersecurity company headquartered in Buenos Aires, Argentina, and with offices in Chile, Peru, Bolivia, and Paraguay. According to the agreement, RAN Security will become a wholly owned subsidiary of Cerberus Sentinel. CISO Global anticipates the transaction will be finalized later this year following customary closing conditions and applicable regulatory approvals. RAN Security offers secured managed services to organizations across South America and is part of a growing network of companies acquired by CISO Global in Latin America, including Arkavia, CUATROi and NLT. “RAN Security expands our growth strategy in Latin America and adds to our SOC/managed detection and response services,” said CISO Global CEO and founder David Jemmett in the press release. “Cybersecurity requires global capabilities to properly address the security demands of businesses and organizations. RAN Security is an excellent cultural fit with the Cerberus Sentinel family of companies.”

To view the full press release, visit https://ibn.fm/yEMvQ

About CISO Global Inc.

CISO Global is an industry leader in managed cybersecurity and a compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CISO.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced that its Data443(R) Antivirus Protection Manager(TM) has received VB100 certification. The certification is administered by Virus Bulletin, an independent organization that has tested antivirus products for more than 25 years. Joining leading organizations such as SentinelOne (NYSE: S), Fortinet (NASDAQ: FTNT), Avast Intego and Tacyon, Data443’s antivirus product is available for Microsoft Windows via desktops, laptops, virtual desktops, database engines, and Azure/AWS/GCP, along with hybrid cloud platforms and standard compute servers. “At Data443, we make every effort to help protect customers from the ever-growing cyber threat environment,” said the company’s founder and CEO Jason Remillard. “Achieving VB100 certification and besting some of the world’s largest competitors on false alarms delivers on our technical market leadership of our antivirus protection and ransomware product line. With so many antivirus products on the market, it can be difficult for consumers and businesses to determine which are truly effective at protecting against malware. VB100 certification helps to cut through the marketing hype and provides a reliable benchmark for comparing antivirus products.”

To view the full press release, visit https://ibn.fm/3U7Tf

About Data443 Risk Mitigation Inc.

Data443 Risk Mitigation (All Things Data Security(TM)) provides data security and privacy management solutions at home, in the small office and across the enterprise for the multi-cloud. Trusted by over 10,000 business customers, the company focuses on organizing the world’s data by identifying and protecting all sensitive data regardless of location, platform or format. For more information, please visit www.Data443.com.

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Amesite’s (NASDAQ: AMST) CEO Dr. Ann Marie Sastry recently sat down for a chat with Benzinga to discuss the Detroit-based company’s past year of successful partnerships and to look ahead to a promising 2023. Dr. Sastry explained how Amesite is an educational technology (“EdTech”) software-as-a-service (“SaaS”) company helping modernize educational systems via its artificial intelligence (“AI”) powered white-label eLearning services. Instead of competing with existing educational infrastructure, Amesite collaborates to update branded programs via its AI-driven platform. “We are proving our theory every day that most professional training as one segment will go online — that is the future,” said Dr. Sastry. “And that online learning has to be great in order for organizations to succeed, in order for brands to succeed, and in order for people to move ahead.”

To view the full video, visit https://ibn.fm/3rJRJ

About Amesite Inc.

Amesite is an artificial intelligence-driven platform and course designer providing online products in the United States. The company uses machine learning to offer a mass customized experience to learners. Its customers include businesses, universities and colleges, K-12 schools, and non-profit organizations. The company was incorporated in 2017 and is headquartered in Detroit, Michigan. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. The company today announced that the last patient has completed the study protocol in its phase 2 clinical trial of PH94B for the treatment of adults experiencing adjustment disorder with anxiety (“AjDA”). “The four-week treatment protocol for our final enrolled patient is complete. This is a major milestone for our team,” said Shawn Singh, chief executive officer of Vistagen. “Along with many other mental health challenges, the prevalence of adjustment disorder is alarming due to increasing levels of health, safety, economic and social stressors that adversely impact mental health and wellbeing. Vistagen is dedicated to developing treatments to address the escalating mental health crisis. We look forward to completing data analysis for this important study over the coming months.”

To view the full press release, visit https://ibn.fm/65fkc

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster-acting and with fewer side effects and safety concerns than those that are currently available. Vistagen’s clinical-stage candidates are targeting multiple forms of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are investigational neuroactive steroid nasal sprays designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

BlockQuarry (OTC: BLQC), a Texas-based company with commercial-stage operations in the energy and infrastructure industry focusing on cryptocurrency mine hosting and self-mining in the Southeast United States, today provided an update to its shareholders. According to the announcement, the company has cancelled $5 million in debt, resulting in a 30% reduction in overall liabilities on its balance sheet. In addition, BlockQuarry was able to extend maturity dates on its remaining notes with its largest debtholder, RB Capital Partners. “I’m very excited about the substantial moves we were able to make with some of our debtholders, including our largest investor, RB Capital. These moves are a key part of our strategy to clean up our balance sheet and help maximize shareholder equity,” said Alonzo Pierce, president and chair of BlockQuarry. “Not only were we able to cancel debt, but we were also able to extend the maturity date on our remaining notes with RB Capital, taking them out of default. This is important, as it will reduce the derivative liabilities that show up on our balance sheet. The company is now in a much stronger position, and shareholder value has undoubtedly increased.”

To view the full press release, visit https://ibn.fm/GsyJq

About BlockQuarry Corp.

BlockQuarry is an energy and infrastructure company focused on cryptocurrency hosting and self-mining operations, with leased properties located within the Southeast United States. BlockQuarry also maintains a fleet of digital/cryptocurrency mining equipment and infrastructure.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Kronos Advanced Technologies (OTC: KNOS), an innovation-driven product development company and creator of patented Kronos(R) CORE air disinfection technology inside its advanced smart air purification devices, today announced that the U.S. Food and Drug Administration (“FDA”) has recently granted 510(k) / Class II Medical Device clearance. According to the update, the FDA clearance was provided after a detailed review of the patented Model 5 device, which utilizes patented High Voltage Field air disinfection technology and is proven to eliminate 99.9% of harmful airborne particles, including allergens, bacteria, fungi, and viruses, like COVID-19. “We are proud that our manufacturer has been granted FDA clearance for the Model 5 Air Purifier, and we want to thank the FDA team for their investigation and test results review of Kronos CORE patented air disinfection technology,” said Michael Rubinov, CEO of Kronos. “We have been developing air disinfection and purification technology since 2002, and we are experts in indoor air quality. The recently approved FDA clearance of the Model 5 device, which is powered by our patented Kronos(R) air disinfection technology, represents a major step forward to marketing our products to hospitals, doctors’ offices, allergy suffers and areas where natural disasters occurred like when wildfires happen.”

To view the full press release, visit https://ibn.fm/p7ZcS

About Kronos Advanced Technologies Inc.

The company was initially founded in 2002 and funded by the U.S. military to develop electrostatic air movers. Eventually, the company moved into the consumer air purification business. It began operations as a product development company that invented and significantly changed the way air is moved, filtered and sterilized. Historically, Kronos has focused on developing, marketing and selling the company’s proprietary air movement and purification technology. Serving the indoor air quality (“IAQ”) market, Kronos technology uses state-of-the-art high-voltage patented processes without the use of traditional porous HEPA filters. Kronos-based products move air silently, filter, sterilize, and purify the air while dramatically reducing energy consumption to half of a 60-watt light bulb. Kronos devices can be variable in shape or size and, therefore, have the potential to be scaled down for air purification in cars or scaled up in size for industrial and hazardous gas destruction. The technology is currently being implemented in multiple standalone products for businesses, homes and vehicles of all types — to move, sterilize and filter air, including removing allergens down to 14.6 nanometers, passing through its patented technology — replacing expensive outdated passive HEPA and other filtration type systems. There are broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices. Examples of immediately addressable markets include schools, universities, health care facilities, operating rooms, manufacturing clean rooms, and the cabins of automobiles and commercial aircraft. For more information, visit the company’s website at www.KronosATI.co.

NOTE TO INVESTORS: The latest news and updates relating to KNOS are available in the company’s newsroom at https://ibn.fm/KNOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, has closed on its previously announced private placement. The placement was with a single institutional investor and resulted in approximately $8 million in gross proceeds. According to the release, the company will receive net proceeds of some $7.4 million after agent fees and estimated offering expenses are deducted. Vivos plans to use the private placement funds for general working capital and corporate purposes to support its efforts in driving revenue growth and managing expenses.

The private placement included 2 million shares of VVOS common stock, prefunded warrants to purchase up to 4,666,667 shares of company common stock and common stock purchase warrants to purchase up to 6,666,667 shares of company common stock at $1.20 per share.

To view the full press release, visit https://ibn.fm/MddfI

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in the treatment of more than 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• Cannabis companies are regarded as being particularly vulnerable to cyberattacks, including potential ransomware incidents, because of their high cash-flow operations and their small business status, heightened by remote work due to Covid
• Cybersecurity services and technology provider SideChannel serves the needs of emerging businesses that may be hard-pressed to hire a full-time cybersecurity expert and need an affordable alternative
• SideChannel provides virtual chief information security officer (“vCISO”) services on a contract basis, drawing on a collective 450 years of experience

When the COVID-19 pandemic caused a wide array of industries to shut down their operations and then reopen with heightened emphasis on remote work, it created a generous opportunity for cyber criminals to exploit the increased business dependence on the Internet for core functions.

Chainalysis, a company that tracks digital transactions on the blockchain, reported ransomware payments from victims surged by 311 percent between 2019 and 2020 to reach nearly $350 million, for example. Ransomware is a cyberattack in which a target’s computer files are accessed and then…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

FE Battery Metals (CSE: FE) (OTCQB: FEMFD), a publicly traded Canadian mineral exploration company, has entered into an option and joint venture (“JV”) agreement with Infini Resources. The agreement outlines how Infini Resources could earn a 100% interest in 255 lithium claims located in Quebec. According to the announcement, FE Battery Metals holds more than 700 claims in the Abitibi region in Quebec; the company also plans to advance exploration efforts on the Augustus and Canada Lithium showings, which are directly adjacent to the NAL Mine currently owned by Sayona Mining Inc. The company anticipates sharing additional details regarding its 2023 exploration program at Augustus Lithium in the future. The announcement also noted that, based on the option agreement, Infini Resources has opted to earn an initial 50% interest by making an initial cash payment of AUD$550,000; once that option is exercised, a JV would be formed between FE Battery and Infini Resources to advance the project. “We are excited to enter into this option agreement with Infini Resources and look forward to exploring new areas of our large land package alongside Infini Resources,” said FE Battery Metals CEO and director Gurminder Sangha in the press release. “FE will continue to focus its exploration efforts on its core claim group with hosts the Augustus and Canada Lithium showings.”

To view the full press release, visit https://ibn.fm/ctliT

About FE Battery Metals Corp.

FE Battery Metals is a Canadian mineral exploration company with a primary focus of acquiring mineral properties in the battery metal sector. The company’s goal is to identify, acquire and explore North American mineral prospects with a primary focus on lithium. It’s strategy is to acquire and advance projects through prospecting and early-stage exploration; source joint venture partners to finance future exploration and project development; and create shareholder value through exploration success. For more information about the company, please visit www.FirstEnergyMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has published new research in the peer-reviewed journal, “Applied Sciences,” as part of a special issue featuring digital therapeutics applications for chronic disease management. The research shows improved outcomes for users living with diabetes across different racial and ethnic groups. According to the announcement, disparities among racial and ethnic groups are common in many chronic conditions, including diabetes. The research evaluated retrospective data from 1,000 individuals diagnosed with type 2 diabetes who used Dario’s platform during a 12-month period. Data from users who identified as White was compared to the data of those identifying as Black, Latino or Asian. The article reported that the gathered data indicated no statistical difference in the levels of engagement across racial and ethnic groups as well as notable improvements in average blood glucose between the first and last month with no statistical difference between racial and ethnic groups. Specifically, the numbers show a 14% reduction in White users and a 15% reduction in Black, Latino and Asian users. “We are thrilled to expand our research on the important topic of digital health as a means to help address health inequities,” said Dario vice president of clinical and scientific affairs Yifat Hershcovitz, PhD, in the press release. “We serve a diverse user population and improving outcomes for everyone is always our goal. This new study provides assurance that our solutions have a positive clinical impact regardless of race or ethnicity.”

To view the full press release, visit https://ibn.fm/9NYdR

About DarioHealth Corp.

DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1), the digital face of the plant-based community operating a one-stop shop for plant-based products, today announced preliminary and unaudited financial metrics for the third quarter of 2022, the period ended Dec. 31, 2022. “We continue to build a diversified platform for sustainable growth, leveraging our expanding presence in the plant-based ecosystem and greater cross-promotional capabilities,” said PlantX CEO Lorne Rapkin. “Recent acquisitions of Little West and EH & Portfolio Coffee are playing key roles in our growth, and our New Deli and PlantX Living expansions are contributing to revenue diversification and market awareness. Geographically, our expansion to the U.K. and Israel have been successful, and we are growing our presence in these important regions. As we enter 2023, we believe this will be a year of continued growth for PlantX.”

To view the full press release, visit https://ibn.fm/K0vhu

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering delivery service for meals and indoor plants, the company currently has plans underway to expand its product lines to include a juice and coffee company. PlantX uses its digital platform to build a community of likeminded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company’s digital presence works to eliminate the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s investor website at https://Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global vendor of push-to-talk over cellular (“PoC”) devices and cellular signal booster systems, today announced that T-Mobile US Inc. (NASDAQ: TMUS), the second largest wireless carrier in the U.S. with more than 111.7 million customers*, will launch Siyata’s rugged SD7 device onto its Internet of Things (“IoT”) data network. T-Mobile is expected to begin selling the SD7, developed to disrupt and replace the multibillion land mobile radio (“LMR”) industry, to the company’s broad enterprise customer base beginning in the first quarter of 2023. “With the addition of T-Mobile, we are significantly expanding our addressable market and entering 2023 in a strong position with all major U.S. wireless carriers now offering SD7 as well as additional partnerships internationally,” said Siyata CEO Marc Seelenfreund. “This relationship with T-Mobile strengthens our network compatibility and further expands our ability to reach first responders and enterprise personnel with a reliable PoC device that can operate extremely well in tough working environments.”

To view the full press release, visit https://ibn.fm/TtPOD

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation push-to-talk over cellular (“PoC”) devices and cellular booster systems. Its in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Its portfolio of enterprise grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. Siyata’s common shares trade on the Nasdaq under the symbol SYTA and its previously issued warrants trade on the Nasdaq under the symbol SYTAW. For more information about the company, visit www.SiyataMobile.com and UnidenCellular.com.

*https://pr.report/plohIcG0

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Prime Harvest, a legal cannabis company focused on tech and parent company to Jaxx Cannabis, was part of an appeal process heard by the Southeastern San Diego Planning Group. In a neighborhood that has shown a “nearly united front” against cannabis outlets that aren’t focused on social equity and neighborhood enrichment, the 8-to-2 vote to approve a conditional use permit process (“CUP”) for Prime Harvest showed public support for the entity. An article, titled “What a Difference a Year Makes — Mt. Hope Gets the Cannabis Outlet They Want,” reports on the successful efforts that the city and county are making to work on social equity programs that address inequality in the cannabis industry. The article noted that, prior to the hearing, Prime Harvest D9 had held multiple meetings with all concerned parties and integrated the needs of the community into its project. Consequently, neighborhood groups showed up at both the public hearing and appeal hearing in support of the company. “At appeal hearings, the public fills out forms marked that they ‘Oppose’ the appeal or are ‘In-Favor’ of the appeal,” the article reported. “Sharon Whitehurst-Payne, who represents southeastern (DE) San Diego on the Board of Education stood at the podium to remind us of neighborhood neglect and say that she would not oppose and may support the Gateway project should they do what they have offered. Quite a few community members spoke, quite a few more turned in slips that they opposed the appeal [against Prime Harvest], but they didn’t speak.  The slip ratio was dozens to one. Not typical which is why this is so interesting.”

To view the full press release, visit https://ibn.fm/zTfo6

About Prime Harvest Inc.

Prime Harvest is a technology-focused, full-service cannabis corporation. The company is horizontally diversified across various segments of the cannabis value chain, including licensing acquisition and compliance management, and statewide direct-to-consumer operations. Based in the innovation hot spot of San Diego, California, Prime Harvest is expanding its footprint throughout the Golden State by executing a long-term strategy of investing in the growth and scale of licensed assets anchored by the power of data-driven technology. Prime Harvest’s flagship retail brand, Jaxx Cannabis, upholds exceptional standards of quality and services and provides a rewarding experience for customers in San Diego and the surrounding Southern California communities. Trust and credibility are at the heart of everything that the team at Prime Harvest stands for. The Prime Harvest team is composed of true experts in their respective fields, carefully assembled with the aim of building a world-class organization that can drive the cannabis industry and movement forward. For more information about the company, visit www.PrimeHarvestInc.com.

NOTE TO INVESTORS: The latest news and updates relating to Prime are available in the company’s newsroom at https://ibn.fm/PRIME

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nutriband (NASDAQ: NTRB), a pioneer in the science of using novel transdermal solutions and other innovative technologies, has kicked off the new by becoming the first NASDAQ company to dual list digital shares on Upstream, a fully regulated global stock exchange for digital securities and NFTs. The company began trading on Upstream yesterday under the ticker symbol NTRB. According to the announcement, the dual listing is designed to provide Nutriband with access to a global, digital-first investor base; potential investors will be able to trade using USDC digital currency as well as credit, debit, PayPal and USD, which will unlock liquidity, enhance price discovery and globalize the opportunity to invest in the company. “We are proud to have a trailblazer like Nutriband as the first company to dual list on Upstream and offer its shares to an international investor base seeking streamlined access to U.S. companies,” said Upstream cofounder Mark Elenowitz in the press release.

To view the full press release, visit https://ibn.fm/HO8TB

About Nutriband Inc.

Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s lead product under development is an abuse deterrent fentanyl patch incorporating its AVERSA(TM) abuse deterrence technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion and accidental exposure of drugs with abuse potential. For more information about the company, please visit www.Nutriband.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Universal Ibogaine (TSX.V: IBO) (“UI”), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered care, today provided a year-end summary of 2022 accomplishments. “2022 was a busy year of behind-the-scenes activity laying the foundations with Health Canada in preparation for the planned clinical trial application and sourcing the related ibogaine drug supply,” said Nick Karos, chief executive officer and board member of Universal Ibogaine. “We are finalizing discussions with several potential funding partners and intend on closing the second round of our current convertible debt financing very shortly. 2023 will be a pivotal year for our company, for our shareholders and for Canadians who are actively seeking ibogaine treatment.”

To view the full press release, visit https://ibn.fm/dvjpV

About Universal Ibogaine Inc. (“UI”)

UI is a life sciences company with a mission to transform addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorder, and ultimately to utilize that protocol globally through planned future licensing agreements. UI is concurrently developing a state-of-the-art holistic addiction treatment protocol at its Kelburn Recovery Centre that, which when paired with the planned ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction. For more information about the company, visit https://universalibogaine.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, and Davidson Technologies Inc., a technology services company that provides innovative engineering, technical and management solutions for the Department of Defense, aerospace and commercial customers, today announced the companies’ entry into a multi-year reseller agreement. At its upcoming annual user conference, Qubits, D-Wave will highlight the new alliance, which enables Davidson to resell D-Wave’s products and services, including the Leap(TM) quantum cloud service. The companies are also collaborating on an initiative to support classified quantum-hybrid applications, an important requirement for national defense programs.

“Davidson has a reputation for recognizing how emerging and advanced technologies can be applied to help customers navigate change, embrace risks and grow,” said Dr. Alan Baratz, CEO of D-Wave. “We share that spirit of imagining the unimaginable and harnessing the power of technology in service to our customers. Through our collaboration, we’re extending Davidson’s impressive portfolio with annealing quantum computing solutions designed to tackle government customers’ increasingly complex computational problems, today.”

To view the full press release, visit https://ibn.fm/2ogtX

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers — and the only company building both annealing quantum computers and gate-model quantum computers. The company’s mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection and financial modeling. D-Wave’s technology is being used by some of the world’s most advanced organizations, including NEC Corporation, Volkswagen, DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory. For more information about the company, visit www.DWaveSys.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

SideChannel (OTCQB: SDCH) CEO Brian Haugli is one of several cybersecurity experts quoted in a recent “Information Week” article outlining five questions to ask about protecting a business. The article mentioned a widespread phishing campaign that took place last August against customer-engagement platform Twilio and content-delivery network Cloudflare. The cyberattack stole nearly 10,000 sets of credentials, with the tally rising much higher if downstream customers that were impacted were included in the count. Haugli addressed the fact that even if a company “has a firm grasp of IAM within their own four walls, risk extends much further. The Twilio supply chain attack had hundreds of secondary victims.” He noted that understanding where vendors are actually being used in the ecosystem beyond “your own four walls” becomes very important for security. “Understanding where your vendors are actually being used, not just for yourself but in a greater ecosystem, becomes very important for your own security,” said SideChannel founder and CEO Brian Haugli in the press release. “Because somebody else’s mishap now becomes your problem. I don’t think we do enough building programs based on standards and recognized frameworks.”

To view the full article, visit https://ibn.fm/X5qhQ

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nutriband (NASDAQ: NTRB), a pioneer in the science of using novel transdermal solutions and other innovative technologies, has announced that it has commenced trading on Upstream, a MERJ Exchange Market that is a fully regulated global stock exchange for digital securities and NFTs. The company, which began trading on Upstream today using the NTRB ticker symbol, is among the first issuers to dual list on the market. The company released a digital collectible NFT commemorating the dual listing, which is available for all Upstream participants to claim with a claim code: NTRB! “We are thrilled to be amongst the first companies to dual list on Upstream’s next generation marketplace,” said Nutriband CEO Gareth Sheridan in the press release. “We are adding new value to our shareholders while expanding our company and mission to a modern, global investor-base.”

To view the full press release, visit https://ibn.fm/9tMVN

About Nutriband Inc.

Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s lead product under development is an abuse deterrent fentanyl patch incorporating its AVERSA(TM) abuse deterrence technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion and accidental exposure of drugs with abuse potential. For more information about the company, please visit www.Nutriband.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has regained full compliance with NASDAQ minimum-bid price requirements. The company received a letter from the NASDAQ Stock Market LLC providing notification of the change in status; the letter was dated Jan. 4, 2023. According to the letter, the exchange determined that the closing bid price of the company’s common stock was at or above $1 per share for 10 consecutive business days, which is the minimum requirement. Therefore, ATNF has regained compliance.

To view the full press release, visit https://ibn.fm/P9tkR

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs that are seeking to address major unmet medical needs. The company’s focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, has entered into a definitive agreement. According to the announcement, the agreement is with a single institutional investor and is estimated to raise $8 million through a private placement offering with a single unit price $1.20. The offering defined each unit as one share of common stock (or a prefunded warrant to purchase one share of common stock) and one warrant exercisable for one share common stock at a price of $1.20 per share for a period of five years and 6 months from closing. The announced noted that no actual units will be issued in the offering. “After the placement agent fees and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $7.5 million,” the announcement stated. “The offering is expected to close on Jan. 9, 2023, subject to customary closing conditions.”

To view the full press release, visit https://ibn.fm/4KDkx

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in the treatment of more than 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, today issued a letter to shareholders from Robert Nistico, SBEV’s CEO and chairman. “As we embark upon 2023, I wanted to take this opportunity to briefly update our shareholders on some key developments that have taken place at Splash Beverage Group since our last corporate update. Since our August update, we have continued to add distribution agreements and retail authorizations. This is a result of positive brand performance in existing accounts, and our growing reputation in the industry. Keep in mind that each new distributor and / or retail chain adds revenue for Splash,” Nistico stated in the letter, further detailing the company’s expansions and growth. “Each of our brands tap into unique trends in consumer preferences, and we believe that we are in the right categories at the right time. We are very grateful to have you as shareholders and we look forward to continuing to earn that confidence.”

To view the full press release, visit https://ibn.fm/ZIP8D

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drink. Splash’s strategy is to rapidly develop early stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, today announced interim results for the first five patients dosed in its Phase II STOP (Study of the Treatment of Overeating utilizing Psilocybin) trial. In collaboration with the University of Florida, the trial is evaluating TRP-8802 (oral psilocybin) in patients with binge eating disorder (“BED”) and represents the first use of psilocybin in conjunction with psychotherapy as a therapeutic intervention in patients with BED. “The magnitude and consistency of the trends observed in this interim analysis are incredibly encouraging,” said Tryp’s CEO Jim Gilligan, Ph.D. “Furthermore, these preliminary results provide us with the confidence that BED is a viable target for future studies with psychedelic-assisted psychotherapy utilizing TRP-8803, our proprietary IV formulation of psilocin that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. Our strategy is to perform small exploratory studies using TRP-8802 for unique indications including BED, fibromyalgia and irritable bowel syndrome, all in partnership with leading academic institutions. Once a positive clinical signal is identified in studies using TRP-8802, we intend to perform subsequent studies with TRP-8803.”

To view the full press release, visit https://ibn.fm/uKc7s

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit has been demonstrated, subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

SideChannel (OTCQB: SDCH) was featured in a recent “Cyber for Hire – The Managed Security Podcast” published by SC Media. The piece delves into factors to consider when paring a company with a fractional or virtual CISO, looking at how to find a harmonious match. SideChannel’s founder and CEO Brian Haugli joined program co-hosts Bradley Barth and Ryan Morris to discuss the facets that go into the role or service to successfully make the solution work for a client long term. “I’ve been across the whole spectrum… Starting and building the company that I’m in, SideChannel, I started out as a solo practitioner. So, I’ve lived that life and figured that out, now scaling it to offer many different CISOs to many different clients,” Haugli said, discussing what he has learned, now seeing the whole gamut of how to make the connection work between personalities and backgrounds. “Geography is actually a big deal, and it’s mostly for the service provider/vCISO,” he said, discussing the need for providers to consider compatibility and adjustments required when working with a client on the east vs. west coast or their various location. “Expertise… that’s probably the largest component,” Haugli further explained, sharing insight on the key requirement for the CISO to serve the clients they are working with.

To view the full podcast, visit https://ibn.fm/vAbfs

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into an exclusive license agreement with the University of Pittsburgh. According to the announcement, the agreement gives Genprex a worldwide, exclusive license to a patent application along with related technology; the agreement also grants the company a worldwide, nonexclusive license to use certain related know-how. The agreement is related to gene therapy for type 2 diabetes using the genes of the Pdx1 and MafA transcription factors. The company believes that the technologies licensed from the university may have the potential to change the course of the disease and provide long-term efficacy for millions of individuals diagnosed with both type 1 and type 2 diabetes. “This marks the company’s third technology license this year supporting our diabetes program, demonstrating the continued strengthening of our intellectual property portfolio, our diabetes program and our position as a lead innovator in emerging diabetes gene therapies,” said Genprex president and CEO Rodney Varner in the press release. “We are thrilled to have secured multiple cutting-edge technologies from Pitt that expand our diabetes gene therapy program and specifically target type 1 and type 2 diabetes.”

To view the full press release, visit https://ibn.fm/qElyq

About Genprex Inc. 

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, which currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, nonviral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic, gene-therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is then administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient in the body. The company’s lead product candidate, REQORSA (quaratusugene ozeplasmid), is being evaluated in two clinical trials as a treatment for non-small cell lung cancer (“NSCLC”), with each of these clinical programs receiving a fast track designation from the Food and Drug Administration, as well as small cell lung cancer. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an endoscope and an adeno-associated virus (“AAV”) vector to deliver Pdx1 (“Pdx1”) and MafA (“MafA”) genes to the pancreas. In models of type 1 diabetes, GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In a similar approach, GPX-003 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• With over 500 million ransomware attacks in 1H2021, corporations have been increasingly looking for ways to safeguard their internal IT systems
• The need for data protection has been further heightened by increased regulatory scrutiny from foreign and domestic governmental agencies
• In the U.S., the recently passed Federal ADPPA privacy law will coincide with California’s Consumer Privacy Act, with the latter set to come into effect on January 1, 2023
• With a broad toolkit focused on data security and management, Data443 have sought to capitalize on the expanding global need for data protection services

Towards the beginning of May 2021, U.S. fuel prices started to unexpectedly spike. The Colonial Pipeline company, operator of a systemically crucial 5,500 mile long pipeline engaged in transporting fuel from the Gulf Coast to the New York metro area was shut down, suspending the flow of over 100 million gallons of fuel every day between Texas and New York (https://ibn.fm/YoGfq). In ensuing days, news would break that DarkSide, an emerging hacking consortium had held the company’s IT systems hostage – freezing its data and threatening to leak sensitive corporate information online. Colonial Pipeline would go on to pay a ransom of $2.3 million or 63.7 bitcoin at the time. Whilst dramatic in nature, the Colonial Pipeline ransomware attack was just one of nearly 500 million ransomware attacks taking place in the first half of 2021, a clear illustration of the need for corporations to engage in more robust cyber security efforts going forward.

Focusing in on data security and a privacy-forward methodology, Data443 Risk Mitigation (OTC: ATDS) has emerged as a key player within the cyber security arena, strategically positioned to benefit from increased demand for data protection with its portfolio of software solutions, allowing for a unified…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, has been modeled around a culture of innovation. This, coupled with the dedication and output of its now more than 200 highly skilled personnel, has propelled the company to be a leader in its market segment. “This status is evidenced by several parameters, including CubCrafters’ average aircraft revenue per customer, which has grown from just over $5 million in 2001 to over $30 million in 2021, according to the company’s Regulation A+ presentation. In fact, the company reported resilient sales as well as a growing market share in 2021 despite pandemic-related supply chain issues,” a recent article reads. “As a further testament to this leadership, two CubCrafters aircraft are the recipients of only a handful of Part 23 certificates that the FAA has issued over the last two decades. Moreover, CubCrafters has been among the very few companies to obtain a new type certificate – an approval that signifies compliance with requirements on airworthiness, design of the aircraft and all component parts, noise, exhaust emission standards, and more – in backcountry aviation since 1970. CubCrafters’ distinctiveness has led to demand for its aircraft, leading to the company being fully booked until 2024.”

To view the full article, visit https://ibn.fm/Sz2QU

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision, and its wholly owned subsidiary Eye-Net Mobile Ltd., have announced a new collision-prediction solution. Called Eye-Zone(TM), the solution is a virtual sensor designed for the automotive industry. Eye-Zone will be on display at CES 2023, which will be held in Las Vegas on Jan. 5–8, 2023. CES visitors will be able to meet key members of the Eye-Zone team during the show as well as enjoy a behind-the-wheel experience on Eye-Net’s 3D driving simulator. According to the announcement, Eye-Zone is a vehicle-to-everything (“V2X”) collision-detection and accident-prevention solution designed to notify the driver through a unique virtual sensor that provides information about real-time location, movement characteristics and probability of collision with road users around the vehicle. The company noted that Eye-Zone can be integrated with various automotive systems, including Advanced Driver Assistance Systems, navigation systems and infotainment systems.

To view the full press release, visit https://ibn.fm/3Jt80

About Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings is a technology company developing smart multispectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries — Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd. — Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time, precollision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information, visit the company’s website at www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

IBN, a multifaceted financial news and publishing company for private and public entities, today announced the launch of Investor Relations Plus (+), its customized IR solution designed to support both issuers and IR professionals. IBN continually works to adapt to the evolving needs of its client partners, and with offerings such as press release enhancement through InvestorWire, gleans insight from traditional PR professionals and IR firms while strengthening its value proposition for both public and privately held companies operating across a wide spectrum of industries. “Many of the investor relations firms and professionals we’ve worked alongside over the past 17+ years have appreciated our team’s ability to help out in more areas than content creation and distribution,” said IBN’s Director of Client Solutions Christopher Johnson. “With the introduction of Investor Relations Plus (+), we have a new solution that can provide a full array of traditional investor relations services to help issuers and IR professionals wherever needed.”

To view the full press release, visit https://ibn.fm/tK66t

About IBN

IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (“DBP”), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA), a diversified clinical-stage company developing products to improve survival and/or the quality of life for patients with unmet medical need conditions, today announced that its CEO Dr. David Young will present an update on Processa’s future therapeutic focus and strategy at the upcoming Biotech Showcase. The presentation is scheduled to begin at 10 a.m. PT on Jan. 11, 2023. Interested parties should visit https://ibn.fm/LcSFO to register for and access the webcast. In addition, the company’s management will be available for one-on-one meetings with potential investors and partners in San Francisco throughout the J.P. Morgan 41st Annual HealthCare Conference week. Meetings can be requested through the Biotech Showcase partnering platform or by contacting Processa directly at [email protected].

To view the full press release, visit https://ibn.fm/Z92Fb

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses its Regulatory Science Approach criteria when selecting and developing drugs to achieve high-value milestones effectively and efficiently. Current clinical pipeline programs include: Next Generation Capecitabine PCS6422 (metastatic colorectal cancer, breast cancer), PCS3117 (pancreatic and other cancers), PCS11T (small cell lung and other cancers), PCS12852 (gastroparesis, functional constipation), and PCS499 (ulcerative necrobiosis lipoidica). Members of the Processa development team have been involved with more than 30 approvals for indications in almost every division of the FDA (including drug products targeted to orphan disease conditions) and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (“OSA”) and snoring in adults, has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for its own daytime-nighttime appliance (“DNA”). According to the announcement, the clearance for the DNA appliance as a Class II device “gives rise to a completely new treatment regimen for mild-to-moderate OSA.” Vivos noted that the device is the company’s longest standing appliance and sees the widest use among Vivos-trained dentists. “This clearance is the culmination of years of pioneering clinical work,” said Vivos Therapeutics chair and CEO Kirk Huntsman in the press release. “For the first time, the FDA has formally recognized the benefits of our proprietary core technology in our DNA appliance (without mandibular advancement) as an effective treatment for mild-to-moderate OSA in adults. The FDA now joins other international regulatory bodies in recognizing the efficacy of our patented technology in the reduction and resolution of many of the symptoms of OSA that result from a lack of development of the jaws and oral cavity. We believe the DNA treatment can be life changing for many OSA patients, and we look forward to continued market adoption of our expanded menu of treatments for this debilitating condition.”

To view the full press release, visit https://ibn.fm/Cs0RT

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution. It has proven effective in the treatment of more than 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that research evaluating the company’s gene therapy for type 1 diabetes will be presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (“ATTD”). The preclinical data will be presented by GNPX research collaborators at the University of Pittsburg. The conference will be held in Germany on Feb. 22 through 25, 2023. The presentation, which is titled “Pancreatic Intraductal Infusion of Adeno-Associated Virus to Treat Non-Human Primates in a Toxin-Induced Diabetes Model,” will be delivered by Ranjeet Kalsi, DO, who will be representing the laboratory of Dr. George Gittes, MD, a professor of surgery and pediatrics and chief of the Division of Pediatric Surgery at the University of Pittsburgh School of Medicine. The presentation is scheduled for Feb. 25 at 1:45 p.m. Central European Standard Time.

To view the presentation, visit https://ibn.fm/EIf2y

To view the full press release, visit https://ibn.fm/x2zZN

About Genprex Inc. 

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, which currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, nonviral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic, gene-therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is then administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient. The company’s lead product candidate, REQORSA (quaratusugene ozeplasmid), is being evaluated as a treatment for both non-small cell lung cancer (“NSCLC”), with each of its clinical programs receiving a fast track designation from the Food and Drug Administration, and small cell lung cancer. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an endoscope and an adeno-associated virus (“AAV”) vector to deliver Pdx1 (“Pdx1”) and MafA (“MafA”) genes to the pancreas. In models of type 1 diabetes, the genes express proteins that transform alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In type 2 diabetes, where autoimmunity is not at play, it is believed that exhausted beta cells are also rejuvenated and replenished. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF) today announced the publication of a review entitled “Dupuytren’s disease: a localized and accessible human fibrotic disorder” in the journal Trends in Molecular Medicine. In the article, the authors at the University of Oxford, led by Professor Jagdeep Nanchahal, chairman of the medical advisory board of 180 Life Sciences, describe the biology of Dupuytren’s disease, to which their important contributions are recognized by the International Dupuytren Award in 2019, 2020 and 2021. “This review provides an important update on our understanding of molecular basis of Dupuytren’s disease,” said Professor Marc Feldmann FRS, co-chairman of 180 Life Sciences. “By unravelling the signaling pathways and demonstrating their link to the genetics, Professor Nanchahal and his colleagues identified tumor necrosis factor (‘TNF’) as a therapeutic target in the laboratory and went on to demonstrate the efficacy of anti-TNF for the treatment of early-stage Dupuytren’s disease in a phase 2b clinical trial, the results which have been previously announced. Importantly, they have recently shown that anti-TNF treatment could also be cost-effective.”

To view the full press release, visit https://ibn.fm/zE5pu

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs, which are seeking to address major unmet medical needs. The company’s focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor).

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at http://ibn.fm/ATNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel’s (OTCQB: SDCH) CEO and Founder Brian Haugli was featured in a recent podcast produced by Hacker Valley Studio. The discussion centers around strategy and leadership in cybersecurity, with Haugli sharing what he has learned about a purposeful approach. “Strategy is not technology, it’s figuring out what you want to look like when you grow up, in a sense,” Haugli said, discussing his philosophy and the tenants in creating a strong security strategy. “Everyone jumps to the shiny object. What can I buy to go solve this problem? You never stop and question: Was that the first problem I was supposed to solve? … I think a lot of people throw strategy around as a grander concept and don’t actually think about the elements that need to go into building one. You need to align to a definition that supports your business and outcomes, and that’s what is strategic.”

To view the full article, visit https://ibn.fm/THPDg

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Companies that experience data breaches face, on average, $4.35 million in consequential costs, demonstrating the importance of an effective cybersecurity response
• Small to medium-sized businesses (“SMBs”) generally find the costs of hiring full-time cybersecurity experts to be prohibitive, making it difficult for them to effectively protect themselves from potential cyber crimes
• Virtual chief information security officer (“vCISO”) services are filling the breach with expert cybersecurity consultancy provided on a contract basis that is far more affordable than a full-time hire
• Cybersecurity services and technology provider SideChannel Inc. provides vCISO consultancy as well as proprietary Enclave software that addresses access control needs through microsegmentation
• SideChannel recently reported that its solutions have resulted in 71 percent YOY revenue growth with vCISO-specific services rising 93 percent and recurring software & services growing 367 percent

The industry providing virtual chief information security officer (“vCISO”) services is positioned to grow, given that cybercrime is one of the fastest-growing crimes in the United States and that the average cost of a data breach is $4.35 million, but the cost of hiring a full-time staff CISO can itself run into the hundreds of thousands of dollars, a recent Forbes report notes (https://ibn.fm/1qTwi).

Virtual CISOs provide high-level security service as a consultancy contract without the need for committed staffing, offering a more affordable option. Cybersecurity services and technology provider SideChannel (OTCQB: SDCH) is demonstrating the popularity of vCISO solutions for…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, today announced its participation in the 25th annual Needham Growth Conference. The event is slated to take place from Jan. 10 – 12, 2023, at The Lotte New York Palace in New York City. The company is scheduled to present at 4:30 p.m. ET on Jan. 10, and its management will host one-on-one meetings with investors throughout the conference. Interested parties should visit https://ibn.fm/Qqr0W to register for and access the presentation. In addition, a replay will be available in the Investor Relations section of DoubleDown’s website.

To view the full press release, visit https://ibn.fm/y1jhz

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. Its flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. For more information, visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel’s (OTCQB: SDCH) CEO and Founder Brian Haugli was featured in a recent video interview published by NBC News. The piece discusses an alert issued by the FBI and Homeland Security over cyber attacks targeting the data of teachers, staff and even students as schools come back in session. NBC News’ Tom Winter speaks with stakeholders and experts in the fight against cyber crime as nationwide concerns grow after Los Angeles has seen a trend of these attacks. “These organizations have payroll; they have HR. When I was in the Department of Defense, we used to track some of these groups when they went on holiday and vacations. So, they operate very much like a business,” Haugli said of the threat and the challenge for parents when a child’s digital identity has been stolen. “My kid will inherit this problem and now have to figure this out in ten years. They might go for their first car loan or apply for financial aid and now, suddenly, have all this credit debt…”

To view the full article, visit https://ibn.fm/1sYyL

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PetVivo Holdings (NASDAQ: PETV, PETVW), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals, recently announced that it has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex and MERJ Exchange Limited. According to the announcement, the planned dual listing is designed to provide the company with access to a global, digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in NASDAQ-listed PetVivo. “We are always looking for ways to provide greater liquidity and value to our shareholders,” said PetVivo CEO John Lai. “We see a dual listing on Upstream as being an excellent way to reach a worldwide market of potential new investors who can learn about our company.”

To view the full press release, visit https://ibn.fm/CJ8eS

About PetVivo Holdings Inc.

PetVivo Holdings is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The company’s strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics. PetVivo has a pipeline of seventeen products for the treatment of animals and people. A portfolio of nineteen patents protects the company’s biomaterials, products, production processes and methods of use. The company’s lead product SPRYNG(TM) with OsteoCushion(TM) technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in dogs and horses, is currently available for commercial sale. For more information about PetVivo and its revolutionary product, please contact [email protected] or visit www.PetVivo.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SPYR (OTCQB: SPYR) CEO Tim Matula has released comments regarding the company, which is a diversified technology company developing products leveraging the Internet of Things (IoT) for consumer use and large-scale applications and industries. Matula commented on noteworthy events during 2022 as well as the company’s outlook for 2023. After thanking shareholders, Matula noted that 2022 was “eventful” for SPRY, including the introduction of new management at the beginning of the year as the company evaluated its business and began looking for potential merger acquisitions. That process culminated in June when the company purchased the assets of GeoTraq in a transaction that included the patent and the inventory of more than 13,000 chip sets; SPYR also entered a manufacturing agreement to build the chip sets into finished goods inventory. GeoTraq is a mobile IoT module manufacturer and connectivity provider that offers asset tracking and remote monitoring through mobile IoT modules with global connectivity. “In July we decided began the process of evaluating the performance of our Applied Magix subsidiary,” said SPRY CEO Tim Matula in the press release. “Based on that review, the board of directors concluded that we should focus on our GeoTraq purchase as the market for their products is growing and our belief that with proper funding we would be able to sell the asset tracking devises to a wide range of enterprise customers. On Dec. 12, 2022, we entered into a settlement agreement and release with shareholders resulting in the cancelation and return to treasury of 36,272,684 common shares, representing 10.48% of the issued and outstanding shares of the company as of Dec. 21, 2022. On Dec. 20, 2022, we wound down and dissolved Applied Magix in Nevada, and now we are 100% focused on growing our GeoTraq business, products and services. Our first goal is to complete the over 13,000 chip sets that are ready for assembly. In addition, as we receive further funding our focus will be on expanding our current engineering staff and migrating to 5G chip sets when we order additional chips. We look forward to the new year with enthusiasm as we concentrate all of our efforts on GeoTraq.”

To view the full press release, visit https://ibn.fm/1jt1o

About SPYR Inc.

SPYR Technologies is a technology company focused on the Internet of Things (“IoT”). Through its subsidiary GeoTraq business, SPYR develops and manufactures fully self-contained, ultra-small mobile IoT modules, including Trackertracker-M modules, for asset tracking and location-based services, and Sensorsensor-M modules, used for remote monitoring. SPYR continues to identify and target acquisitions that will grow its footprint in the industry and expand the products it offers consumers, including companies developing artificial intelligence (“AI”) and smart-technology products. For more information about this company, visit https://ir.spyr.com.

NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that it will showcase a live demonstration of its Mono2Stereo(TM) software-based solution at CES 2023. According to the update, the solution is designed to create 3D perception stereo vision from existing cameras to enhance the performance of existing mono-camera based advanced driver assistance systems (“ADAS”). “The year 2022 saw significant strategic developments for Foresight, as several vehicle manufacturers and tier one automotive suppliers engaged in proof of concept (‘POC’) projects to evaluate the company’s 3D stereoscopic solutions to enhance their existing ADAS systems,” said Haim Siboni, chief executive officer at Foresight. “CES 2023 will give us a chance to showcase our unique technological advances, demonstrating how our software-based solution can benefit the automotive industry.”

To view the full press release, visit https://ibn.fm/jF6R9

About Foresight Autonomous Holdings Ltd.

Foresight is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a large Northeast U.S. supermarket chain selected Dario to help improve the cardiometabolic health of its employees beginning in the first quarter of 2023. This marks 100 enterprise contracts signed for DarioHealth and validates its strategic position as a leading provider of integrated digital chronic condition management solutions in the employer and payer markets. “Throughout 2022 we saw that the demand for our integrated multi-condition solutions grow at a steady pace, and the addition of this employer marks a tremendous achievement for Dario. Hitting our goal of 100 contracts by the end of 2022 is a testament to the vision we set forth over a year ago,” said Rick Anderson, president of Dario. “The fact that most of the contracts signed in 2022 and more than 50% of our pipeline are for multiple conditions represents market validation of our multi-condition suite approach. There is a clear trend with enterprise customers seeking multiple conditions from less vendors. Given our multi-condition suite strategy we believe that we are well positioned for growth in the future market.”

To view the full press release, visit https://ibn.fm/LL1wd

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs. The company today announced its entry into a letter of intent with Massachusetts General Hospital (“MGH”), the largest teaching hospital of Harvard Medical School, to fund and conduct a phase 2a clinical trial investigating the effects of psilocybin-assisted psychotherapy in the treatment of patients aged 21+ suffering from irritable bowel syndrome (“IBS”). “MGH is an ideal partner for Tryp to expand on its strategy of utilizing TRP-8802 (oral psilocybin) to explore the clinical potential of psilocybin-assisted psychotherapy in new indications,” said Jim Gilligan, PhD, chief executive officer of Tryp Therapeutics. “With positive results in this study, Tryp would look to continue clinical development in IBS with TRP-8803, our proprietary formulation of IV-infused psilocin, that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. Our ultimate goal is providing even more favorable outcomes and relief to the millions of patients currently suffering from IBS and its associated disorders. With this agreement in place, we will be in a position to submit the relevant IND.”

To view the full press release, visit https://ibn.fm/7cfby

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit has been demonstrated, subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

BlockQuarry (OTC: BLQC), a Texas-based company with commercial-stage operations in cryptocurrency mine hosting and self-mining in the southeast United States, is reporting on its unaudited financial highlights for the three and nine months ended Sept. 30, 2022. Financial highlights of the report show total revenues for the three-month period s of $2.098 million with total revenue for the nine-month period of $4.46 million. The company’s total assets were $10.42 million with current liabilities of $16.4 million. Operational highlights for the period include partnering with a consultant to provide services to support the company’s efforts to uplist to a higher exchange as well as an agreement with Bitmain to amend an existing service framework agreement to increase hosting service fees from $0.05275 per kilowatt hour to $0.07 per kilowatt hour. In addition, the company announced that a board of directors charter has been submitted to the state of Nevada and that it has filed an amended S1 registration statement with the updated Q3 financial reports. The company also significantly reduced its convertible debt with legacy note holders. “I am extremely proud of our third-quarter financial performance, despite very difficult current overall market and cryptocurrency market conditions,” said BlockQuarry president and chair Alonzo Pierce in the press release. “We were able to book a phenomenal quarter that featured continued strong topline growth, and we made substantial headway on key corporate objectives. . . . We were successful in hitting a number of key objectives in Q3, including a necessary reworking of our agreement with Bitmain to protect the company and ensure we are covered during peak power months. We were also able to get our board of directors and advisors finalized as well as hire a consulting firm to help us with the uplisting process.”

To view the full press release, visit https://ibn.fm/CMx2Z

About BlockQuarry Corp.

BlockQuarry focuses on cryptocurrency mine hosting and self-mining operations at a leased property located in Gaffney, South Carolina. BlockQuarry also maintains a fleet of digital/cryptocurrency mining equipment and infrastructure. For more information about the company, visit www.BlockQuarry.io.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sustainable Green Team (OTC: SGTM), an industry-leading wholesale manufacturer and supplier of consumer and industrial wood-based mulch, soil, and lumber products nationwide, announced that CEO Anthony J. Raynor was slated to present at the Global Unity Foundation’s Summit pitch competition; the competition was held Dec. 31, 2022. During his presentation, Mr. Raynor provided an overview of the company’s achievements and highlights for the past year; the presentation also included a review of SGTM’s upcoming opportunities and goals as well as the company’s vision for growth. According to the announcement, the mission of Global Unity Foundation (“GUF”) is to unite the world through humanitarian efforts by working with community leaders, influential individuals and socially conscience organizations to eradicate poverty, advance health and wellness, create economic sustainability and promote universal quality education. “I am excited to share our vision, passion, and plan to positively change our world at the Global Unity Summit and Gala,” said Sustainable Green Team CEO Anthony J. Raynor in the press release. “I believe that there is no greater way to end 2022 than presenting and networking in such a prestigious event as we enter the new year.”

To view the full press release, visit https://ibn.fm/pxs1C

About Sustainable Green Team Ltd.

The Sustainable Green Team is a wholesale manufacturer and supplier of wood-based mulch, soil and lumber products, selling directly to mass merchandisers, home centers, hardware stores, nurseries, garden centers, convenience stores and food stores, in addition to wholesalers and distributors. The company also provides arbor care and storm-recovery services at the residential, commercial and municipal levels while offering green-waste solutions to large- and small-scale waste disposal and recycling companies located throughout the southeastern United States. The company’s subsidiary, Mulch Manufacturing Inc., is the largest provider of cypress mulch in the country. SGTM has entered into an agreement with Australia-based VRM Biologik Group to bring VRM’s world-leading, soil-moisture technology to the Unites States at scale. HumiSoil(R) and XLR8 Bio(R) are soil-treatment products that rebuild soil hydration on a cellular level, improving the soil and the vegetation and agricultural products it supports. The company will make HumiSoil and XLR8 Bio available for home gardens and lawns throughout the United States to help relieve water use in cities as well as to help VRM Biologik Group in its mission to restore productivity in depleted topsoil in 25% of the world’s arable land. For more information about the company, please visit www.TheSustainableGreenTeam.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is reporting positive interim data from its dose optimization study of SPU-21 joint homing peptides for subcutaneous administration of anti-arthritic agents. According to the announcement, SPU-21 is effective in controlling arthritis progression and exhibits positive data in arthritis suppression. The company noted that it is following a development plan utilizing its liposomal joint homing peptides as a potential therapy for rheumatoid arthritis (“RA”). The study is designed to evaluate the disease-suppressive effects of an SPU-21 peptide-guided anti-arthritis drug compared to the drug alone. SILO is working with the University of Maryland, Baltimore to develop the SPU-21 liposomal joint homing peptides. “We believe that the positive results of these latest tests show that our peptide with DEX given subcutaneously was effective in controlling arthritis progression,” said Silo Pharma CEO Eric Weisblum in the press release. “The effect of lipo-DEX was superior to that of DEX alone when both were administered via the SC route. Since patients widely prefer SC administration over intravenous (‘IV’) infusion for multiple reasons, we believe the superiority and practicality of our liposomal joint homing peptide bode well for broad market potential. Meanwhile, we continue to explore other novel therapeutics for optimal pairing with SPU-21, targeting rheumatoid arthritis as our initial indication.”

To view the full press release, visit https://ibn.fm/X9YF3

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research indications such as Alzheimer’s disease, PTSD and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research that the company believes will be transformative to the well-being of patients and the health-care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• CubCrafters recently announced that the US Department of Agriculture Wildlife Service had selected its flagship FAA-certified CC19 XCub for a new government aircraft-fleet-modernization contract
• The contract extends a long-term working relationship that has seen CubCrafters supply aircraft to various federal agencies since 2003
• CubCrafters aircraft have a lower operational cost than helicopters in addition to being reliable and safe with much of the same capability
• According to CubCrafters, the aircraft fleet modernization contract is important not only to the company as a supplier but also to investors participating in its ongoing public offering, which was recently qualified by the SEC

For close to two decades now, CubCrafters, a Yakima, Washington-based designer and manufacturer of Part 23 Certified, Experimental, and Light-Sport backcountry aircraft, has supplied aircraft to various US Federal Government agencies, including the US Air Force Research Laboratory, the US Air Force Flight Academy, the US Department of Agriculture (“USDA”), the US Department of Homeland Security (“DHS”), and the US Department of the Interior (“DOI”).

“Our long relationship with the US Government is a strong testament to our ability to design and manufacture exceptionally rugged utility aircraft for backcountry missions,” says CubCrafters President and CEO Patrick Horgan of the relationship that began in…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Blue Hat Interactive (NASDAQ: BHAT), a leading communication services and internet data center (“IDC”) business provider, producer and developer, as well as an operator of mobile games and augmented reality (“AR”) education curricula and products in China, is reporting unaudited financial results. The results are for the second quarter 2022, or the three months ended June 30, 2022, and the first half of 2022, or the six months ended June 30, 2022. Highlights of the report include Q2 2022 total revenues of $1.7 million, gross profit of $1 million, loss from operations of $3.3 million and net loss from continuing operations of $3.4 million. First half 2022 numbers reached total revenues of $2 million, gross profit of $1.2 million, loss from operations of $6 million and net loss from continuing operations of $6.2 million. The company also reported $3 million in cash and cash equivalents as of June 30, 2022. The report noted that the global COVID-19 pandemic has negatively impacted the company’s financial performance. “In order to cope with the current situation of the economy environment, some adjustments have been made to the company’s business, and the company has suspended or reduced the AR Immersive Course (“ARIC”), game and communication business, which were severely affected by the COVID-19 pandemic,” said Blue Hat Interactive CEO Xiaodong Chen in the press release. “The company has increased the commodity supply chain commodity trading platform project and increased the breadth of the company’s business. At the same time, the company has increased the investment and development of some new projects such as new energy graphene, which will provide some foundation for the future development of the company, to grow the company steadily and maximize shareholder value.”

To view the full press release, visit https://ibn.fm/wVll2

About Blue Hat Interactive Entertainment Technology

Blue Hat is a leading communication services and IDC business provider as well as a producer, developer and operator of AR interactive entertainment games, toys and educational materials in China. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, has filed its interim financial statements for the six-month period ended Sept. 30, 2022. The company has also filed associated management’s discussion along with analysis and related officer certifications for the same period. Highlights of the report include gross revenue for the company totaling $8,869,579 and cost of goods sold reaching $5,542,113. Net loss for the six-month period was $8,964,219. The company also stated that, as it has filed the interim filings, together with the filing of its audited annual financial statements for the year ended March 31, 2022, as well as associated management discussion and analysis and related officer certifications, it anticipates applying to the British Columbia Securities Commission for full revocation of the “failure to file” cease trade order (“CTO”) issued by the commission in October 2022. “Trading is expected to resume on the Canadian Securities Exchange shortly after the revocation of the CTO,” the company said in the announcement. “The company is now current with all regulatory financial statement filings.”

To view the full press release, visit https://ibn.fm/zexPo

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX is the one-stop shop for everything plant based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering meal and indoor-plant deliveries, the company currently has plans to expand its product lines to include cosmetics, clothing and its own water brand. However, the business is not limited to an e-commerce platform. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

VistaGen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has recently filed national applications at the U.S. Patent and Trademark Office designed to provide additional patent protection for its lead product candidate, PH94B. The company has also filed similar applications with counterpart patent authorities in major pharmaceutical markets outside the United States. The filings are related to PH94B and the treatment of adjustment disorder (“AjD”). According to the company, these filings are a strategic “next step” in VistaGen’s ongoing efforts to enhance potential commercial protection across its CNS pipeline in key pharmaceutical marketsand provide global exclusivity platform for PH94B in AjD; the company is working to provide patent protection that is similar to that of its protection for PH94B for the treatment of social anxiety disorder (“SAD”) as well as its exclusive late-clinical stage product candidate, PH10, for the treatment of major depressive disorder (“MDD”). The company also noted that it is in the process of finalizing an acquisition of its acquisition of Pherin Pharmaceuticals Inc., which will include Pherin’s entire pherine pipeline as well as intellectual property rights to PH94B, a substance that is in phase 3 development for the treatment of SAD and phase 2 development for the treatment of AjD with anxiety (“AjDA”), and PH10, which is in clinical development for MDD. The acquisition will also give VistaGen full ownership of three new early clinical-stage pherine product candidates: PH15 for cognition improvement, PH284 for appetite-related disorders, and PH80 for migraine and hot flashes.

To view the full press release, visit https://ibn.fm/OVJEk

About VistaGen Therapeutics Inc.

VistaGen is a late clinical-stage CNS-focused biopharmaceutical aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than those that are currently available. VistaGen’s clinical-stage candidates are targeting multiple types of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are odorless and tasteless investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. VistaGen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression — one mind at a time. For more information about the company, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has released a letter to shareholders; the letter is signed by CEO James Woody. In the letter, Woody notes that the company’s priority continues to be its clinical programs, repurposing anti-tumor necrosis factor (“TNF”) drugs for the treatment of Dupuytren’s disease, frozen shoulder and post-operative delirium. Woody reports that results from the company’s phase 2B trial exceeded expectations and showed that the treatment will most likely be cost effective. In the letter, Woody stated that, after obtaining scientific advice from the UK Medicines and Healthcare products Regulatory Agency (“MHRA”) and after discussions with regulatory consultants in the United States and United Kingdom, the company is preparing the material required to seek marketing authorization in the UK; the company plans on filing the application in mid-2023. “Enrollment to the trial of anti-TNF for early-stage frozen shoulder is slower than anticipated in the UK as patients typically present to physical therapists and the processes are subject to delays,” stated 180 Life Sciences CEO James Woody in the shareholder letter. “In the USA, all such patients are seen by orthopedic physicians, who are relatively easy to access. The trial team has implemented several strategies to improve recruitment, and we hope that these will be effective. Preparation for the trial of anti-TNF to prevent the development of postoperative delirium remains on track, and we anticipate that the first patient will be recruited in the first half of 2023. Our focus remains on our clinical portfolio. . . and we plan to continue to evaluate the timing and cost/benefit of additional ongoing research for our early discovery programs.”

To view the full shareholder letter, visit https://ibn.fm/ZkCj1

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease: inflammation. The company is driving groundbreaking studies into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli was one of several cybersecurity experts quoted in a recent PEW article reporting on the fact that at least 18 state governors have banned the use of the social media app TikTok on government devices. The article, titled “Governors’ TikTok Bans Make Sense, Cybersecurity Experts Say,” note that the state leaders are concerned about potential security risks because the app is owned by a Chinese company and may be used to collect data from users’ devices. The article contains quotes from numerous cybersecurity experts in support of the action, which could be viewed as political; all the states making the decision were led by Republican governors. Some governors took further action, banning other Chinese-owned apps and products such as WeChat, QQWallet and AliPay. Haugli was also quoted in an online article published by The Information titled “TikTok Owner Now Aiming to Expand into U.S. Enterprise Software Market.” In addition, the PEW article noted that bipartisan action had been taken on the federal level, with the U.S. Senate unanimously passing a bill that would prohibit federal employees from using TikTok on government-owned devices. “TikTok can access your camera and phone, the Wi-Fi connection, contacts, GPS, storage. It can read what you are doing and the things you’ve done,” said SideChannel CEO Brian Haugli in the article. “That thing can tell you where your eyeballs are looking.”

To view the full articles, visit https://ibn.fm/DAw0r and https://ibn.fm/gtFUC

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, today announced that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for Standard Lithium’s third U.S. patent application. The application, serial no. 16/895,783, titled “Process for Recovering Lithium from Brines,” is in addition to Standard Lithium’s other two U.S. patent applications for which Notices of Allowance have been earlier issued by the USPTO. The three applications comprise a portion of Standard Lithium’s novel and proprietary technique for continuous Direct Lithium Extraction (“DLE”) from lithium brines. “We are pleased to have received the Notice of Allowance for the final U.S. patent application of the company’s lithium extraction technology,” said Dr. Andy Robinson, Standard Lithium’s president and COO. “We will continue to strengthen our IP portfolio, but, more importantly, we are actively advancing our south Arkansas lithium projects and doing so by applying sustainable, scalable and fully-integrated modern processing technologies to unlock new U.S. commercial lithium production.”

To view the full press release, visit https://ibn.fm/zQWn9

About Standard Lithium Ltd.

Standard Lithium is a leading near-commercial lithium development company with a portfolio of projects in process. The company’s flagship projects, the LANXESS Property and the South West Arkansas Project, are located in southern Arkansas near the Louisiana state line. The company is focused on the evaluation and testing of commercial lithium extraction and purification from brine sourced from approximately 180,000 acres of unitized leases across these two projects. The company operates a first-of-a-kind industrial-scale Direct Lithium Extraction (“DLE”) Demonstration Plant at the LANXESS Property Project. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. A Definitive Feasibility Study (“DFS”) and Front-End Engineering Study (“FEED”) for Phase 1A of the LANXESS Property Project commenced in September 2022. A Preliminary Feasibility Study (“PFS”) of the South West Arkansas Project commenced in May 2022. The company is also pursuing the resource development of approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California. Standard Lithium is jointly listed on the TSX Venture Exchange and the NYSE American under the trading symbol SLI and on the Frankfurt Stock Exchange under the symbol S5L. For more information, please visit the company’s website at www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• SideChannel is a company focused on making cybersecurity simple and accessible based on the belief that all companies, including small and mid-sized businesses, deserve top-tier security guidance
• Currently, companies are facing the potential of stiffer economic times, demanding more cost-effective solutions to maintain and grow operations
• In these uncertain times, SideChannel offers a significant cost advantage as it provides top-tier security guidance at a manageable cost

In response to tighter budgets, companies have been focused on reducing expenses, streamlining operations, managing cash flows, and building cash reserves, among other interventions. At the same time, companies are recognizing the growing importance of cybersecurity. A November 2022 Global Tech Investment Predictions Report published by IBM and Morning Consult ranks cybersecurity solutions as the second top technology companies plan to invest in over the next two years, after 5G. The report further lists cyber risks as the leading factor driving investments in technology in organizations (https://ibn.fm/sMTnN). Furthermore, separate predictions expect the rising cybersecurity threats and risks to continue into 2023 and beyond (https://ibn.fm/nvHfO), crystallizing the decision by companies to pursue the above investments.

The need to control costs is forcing companies to prioritize less expensive services over costlier products (https://ibn.fm/P61Hn). Coupled with the growing demand for cybersecurity, companies are aggressively seeking the most cost-effective solutions to keep their operations safe. The situation works to the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• CubCrafters is a producer of best-in-class backcountry aircraft made under the light sport, experimental, and FAA-certified (Part 23 certified) aircraft categories
• In 2022, the company achieved several milestones, including filing and receiving qualification for a public offering under the Regulation A+ exemption, marking the first time the company has opened to outside investment in its 42-year history
• The company aims to raise $50 million, channeling the proceeds from the offering toward accelerating manufacturing, enhancing manufacturing capabilities, furthering innovation, and improving customer service
• CubCrafters also released a new, improved engine for its Experimental aircraft
• In addition, CubCrafters announced its flagship XCub aircraft had been selected by the United States Department of Agriculture (“USDA”) for a new government aircraft-fleet-modernization contract

Though not new, backcountry aviation has exploded in the past 25 years, according to an article in the Plane&Pilot Magazine, driven in part by pilots’ need to fly their own aircraft for the rewards of the experience and adventure (https://ibn.fm/Zguzn). This growth has pushed demand for backcountry aircraft capable of taking off and landing on varied rough terrain or water, let alone well-groomed and paved runways.

For a backcountry aircraft manufacturer whose history spans more than 40 years, CubCrafters has witnessed firsthand the explosion of the industry. And to quench aviation enthusiasts’ ever-growing desire for backcountry and light aircraft, the Yakima, Washington-based company has been growing…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, is reporting on its extraordinary general meeting of shareholders, which was held on Dec. 28, 2022 (Korea Standard Time) or Dec. 27, 2022 (U.S. Eastern Time). The meeting was held in Seoul. During the meeting, shareholders of record approved the reduction of the company’s capital reserve in the amount of KRW 330 billion; the reduction was proposed by the company’s board of directors.

To view the full press release, visit https://ibn.fm/Fgn6a

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. For more information about this company, please visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH) was featured in a recent article published by the Worcester Business Journal (“WBJ”). The piece highlights SideChannel’s 71% year-over-year revenue increase in fiscal 2022, in its first report since combining with Austin encryption company Cipherloc Corp. “Cipherloc announced the acquisition of SideChannel on July 5, saying the combined company would take the name of the Worcester firm. In a Tuesday press release, the company called the merger a business combination and determined that SideChannel was the acquiring entity for accounting purposes,” the article reads. “Our 2022 performance demonstrates our continued strength and position in the market across both product and service delivery,” SideChannel CEO Brian Haugli was quoted as saying. “Our investments in sales and marketing, coupled with our expanding cybersecurity, privacy and risk management capabilities, has proven to be effective at acquiring new clients and retaining existing relationships.”

To view the full article, visit https://ibn.fm/7NPoP

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

iClick (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced its board of directors has approved a share repurchase program. Under the program, the company may purchase its own ADSs with an aggregate value of up to US$5 million from Jan. 1 to Dec. 31, 2023. The company intends to fund the repurchase from its existing cash balance, including cash generated from its operations. iClick expects to effect the proposed share repurchase on the open market at prevailing market prices, in negotiated transactions off the market and/or in other legally permissible means as conditions warrant in compliance with applicable requirements of Rule 10b5-1 and/or Rule 10b-18 under the U.S. Securities Exchange Act of 1934, as amended, at times and in such amounts as the company deems appropriate.

To view the full press release, visit https://ibn.fm/T09M8

About iClick Interactive Asia Group Limited

Founded in 2009, iClick is a leading enterprise and marketing cloud platform in China. iClick’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

CubCrafters was featured in a recent article published by AVweb, the world’s premier independent aviation news resource. The piece, written by Mark Phelps, delves into CubCrafters’ recent strategic acquisition. “Just in time for ski season, backcountry aircraft icon CubCrafters is showing its fiscal savvy by acquiring Summit Aircraft Skis. The manufacturer of Part 23-certified, light-sport and experimental aircraft bought the design and manufacturing assets, unique patents and related intellectual property of Sandpoint, Idaho-based Summit Aircraft Skis, which are ‘favored by [CubCrafters’] Carbon Cub aircraft owners and preferred by the owners of many other types of non-CubCrafters manufactured backcountry capable aircraft,’ according to the CubCrafters press release,” the article reads. Brad Damm, CubCrafters’ vice president, is quoted as saying, “Summit Skis, when combined with the outstanding wintertime defrost and cabin heater technology used on our FX-3 model, makes that aircraft the ultimate ski airplane.”

To view the full article, visit https://ibn.fm/ubEK6

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH) was featured in a recent article published by TechDecisions. The piece highlights SideChannel’s launch of the Enclave microsegmentation platform, which offers small to mid-sized businesses (“SMBs”) a solution to simplify and maintain a segmented network with minimal IT administration and maintenance. Enclave is designed to enable IT personnel to easily segment their company’s network, quickly organize individuals and machines to each individual’s workload level, then implement security controls across all segments. “Small and mid-market companies are incredibly challenged by a lack of cost-effective means to comfortably and securely handle network management,” one of the lead developers behind Enclave, SideChannel’s executive vice president David Chasteen is quoted as saying. “These companies want to focus on their business and their customers; not worry about who is accessing what server, or if the encryption installed is sufficient. We built Enclave to provide these companies an affordable and effective segmentation solution that significantly reduces the amount of effort required, through a simple and intuitive interface.”

To view the full article, visit https://ibn.fm/iN02B

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, has filed its restated audited consolidated comparative financial statements and accompanying management’s discussion and analysis for the year ended March 31, 2021. The company also filed its annual financial statements for the year ended March 31, 2022, along with its associated management’s discussion and analysis and related officer certifications. The company also noted that it is in the process of completing its interim financial statements, associated management’s discussion and analysis and related officer certifications for the three-month period ended June 30, 2022; it is also working to file its interim financial statements, associated management’s discussion and analysis and related officer certifications for the six-month period ended Sept. 30, 2022.

To view the full press release, visit https://ibn.fm/l26mH

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX is the one-stop shop for everything plant based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans to expand its product lines to include cosmetics, clothing and its own water brand. However, the business is not limited to an e-commerce platform. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics and food/beverage industries, is sharing projections for its Q4 2022 revenue. According to the announcement, the company anticipates revenue for the last quarter of 2022 to “exceed quarterly revenue for any quarter over the past four years, and may achieve the highest quarterly revenue ever for the company.” PBIO attributed the growth to foundations built and momentum achieved earlier in 2022, which was driven by the commercial release of the company’s revolutionary Ultra Shear Technology(TM), or UST(TM) platform. “Our development of UltraShear over the past six years presented a pivotal, game-changing nanoemulsions technology that we believe will restate the basis of competition for a myriad of products across multiple major industries,” said Pressure BioSciences president and CEO Richard T. Schumacher in the press release. “We have assembled a strong and differentiated IP position and unique engineering and scientific expertise to unleash this opportunity, for PBI and for clients worldwide. We made the critical decision in early 2022 to pivot our business focus and resources almost entirely onto accelerating the UltraShear platform, building commercial-stage UST processing equipment, creating pivotal technology demonstrations with select partners in multiple industries, and accelerating our path to commercial traction and a revenue growth inflection. . . . Astonishing early demonstrations of UltraShear’s unique differentiation of products continue to mount up, and more partners and early marketing results are gathering already for revenue acceleration in Q1 and throughout all of 2023. We are grateful daily for the patient support of our many long-term investors, and we are excited to have them at our side as PBI enters an exciting new era of revenue growth, profitability, and a planned uplist to a national exchange in 2023.”

To view the full press release, visit https://ibn.fm/07VHI

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented-enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control biomolecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of PBIO’s pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has closed on its previously announced registered direct offering. The offering, which was with a single healthcare-focused U.S. institutional investor, was comprised of 1,714,286 shares of the company’s common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,571,429 shares of common stock. The units were priced at $3.50 per share and accompanying warrant. According to the announcement, the warrants have an exercise price of $3.50 per share and are initially exercisable beginning six months following the date of issuance; they also expire five years from the initial exercise date. Gross proceeds from the offering total an estimated $6 million, which the company anticipated using for R&D expenses as well as general corporate purposes.

To view the full press release, visit https://ibn.fm/6Zcaj

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs that are seeking to address major unmet medical needs. The company’s focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing aid space, has announced its subsidiary HearingAssist, America’s No. 1 affordable OTC hearing aid brand, has launched its FDA-registered OTC rechargeable hearing aids on CVS.com. HearingAssist OTC hearing aids also launched in eight selected CVS pharmacy locations in Massachusetts and Rhode Island. “This latest launch of HearingAssist OTC rechargeable hearing aids with CVS and on CVS.com is a result of our continuing efforts to execute our wholesale distribution plan,” said Matthew Moore, president and CEO of InnerScope. “Having both InnerScope’s Hearing Assist and iHEAR OTC hearing aid brands listed on CVS.com and HearingAssist Rechargeable OTC hearing aids in eight selected CVS pharmacies expands InnerScope’s category presence within CVS’s OTC hearing aid market segment. We believe that when customers compare all the features of HearingAssist and iHEAR OTC hearing aids deliver against the cost and features of the other competitors, we will come out ahead.”

To view the full press release, visit https://ibn.fm/WahTi

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s hearing products and its B2C and B2B business model break through the persistent barriers that prevent access to effective and affordable hearing solutions. InnerScope’s recent acquisition of iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, gives the company access to over 40 patents and an R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced hearing products through Walmart and many other major retailers and pharmacy chains. InnerScope’s full line of hearing products is currently available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, CVS.com, RiteAid.com, BestBuy.com, Amazon.com, Fingerhut.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, Cardinal Health(TM) at-Home, Carewell.com, FSAStore.com , HSAStore.com, WellDeservedHealth.com, and Topco Associates, representing 1000s of stores. Coming soon: Wakefern Food Corp. / ShopRite / SpartanNash / VG’s Grocery / Family Fare / Martin’s Super Markets. More in-store and online hearing products will soon launch with major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services (OTCQB: SHRG) is dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The company recently introduced the traveling world to a whole new approach to savings as well as a unique opportunity for those looking for additional income in the gig economy through the inaugural event for Hapi Travel Destinations. “A wholly owned subsidiary of Sharing Services, Hapi Travel Destinations is a global leader in fun-filled, one-of-a-kind travel and offers exclusive travel-club membership… Sharing Services unveiled Hapi Travel Destinations in September, noting that the unique membership-based travel club was specifically designed for travelers to enjoy maximum savings and travel perks on the most luxurious vacation getaways throughout the world while also saving money on ordinary daily personal or corporate travel,” a recent article reads. “Our timing could not be better,” Hapi Travel VP Dave Dove is quoted as saying. “After two years of social distancing and limited travel, people are ready to get out and experience new locations and revisit the places they love. Unfortunately, the rising costs of travel now make this difficult for the average family. Our unique memberships are tailor-made to give access to deep savings for weekend getaways, resort vacations, business travel, flights and hotels. We back this program with a 110% guarantee.”

To view the full article, visit https://ibn.fm/HudLe

About Sharing Services Global Corporation

Sharing Services is a publicly traded company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling sector and other industries. Sharing Services’ combined platform currently leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors. For more information, visit www.SHRGInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has announced that it is “adding contracts with self-insured employers and national health plans as Amazon and CVS vie to lead value-based, patient-centric virtual healthcare.” According to the announcement, digital healthcare is delivering both better health outcome and also lower costs for the national health-care sector. Dario’s proprietary offering features a user-centric, multichronic condition platform and suite of solutions designed to deliver personalized and dynamic interventions based on data analytics; the platform also includes one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The platform provides a turnkey, one-vendor solution for payers, observed DarioHealth. The company has consistently announced new contracts, most recently signing an agreement with a “jumbo” global employer account that represents the increasing penetration of the Dario platform. The announcement also noted that DRIO is delivering on its goal to sign 100 enterprise contracts by the end of year; the company is also reporting a strong balance sheet with $68 million in cash and equivalents as of June 30, 2022, and an additional $25 million of availability on an existing credit facility. DarioHealth is “well positioned and capitalized, signing significant contracts with large clients,” the company stated in the announcement. “The digital therapeutics market is being forced to consolidate with pressure from consumers to deliver healthcare on a value-based system. With Dario’s clinically verified ROI to payers lowering costs for the national healthcare sector, DRIO is clearly delivering in a high-demand market. Investors looking to capitalize on the digital health sector need to put DRIO on their radar.”

To view the full press release, visit https://ibn.fm/Iq2Sh

About DarioHealth Corp.

DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its October and November production as well as forecasting numbers for the remainder of the year; the company also released its guidance for 2023. According to the announcement, total production for October and November reached an estimated 26,700 gold equivalent ounces (“GEO”) with preliminary costs per ounce from McEwen’s 100%-owned operations of $826 for cash costs and $1,088 for all-in sustaining. The report noted that at San José Mine, costs per ounce for October and November were $1,361 for cash costs and $1,745 for all-in sustaining. The report also noted that consolidated production guidance for 2023 represents an 11% to 25% increase from 2022 forecast production. The bottom line? Production is increasing and costs per ounce are falling, the company stated. “As we end 2022, we would like to give our shareholders an update on our recent production results and costs, which illustrate the turnaround we are executing as well as our guidance for 2023. We had a difficult start to 2022, but it is clear that we are trending up and in the right direction as we move into the new year,” said McEwen Mining chair and chief owner Rob McEwen in the press release.

To view the full press release, visit https://ibn.fm/Wm5Kx

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, it owns 68% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. McEwen’s chair and chief owner has personally provided the company with $220 million and takes an annual salary of $1. To learn more about the company, visit www.McEwenMining.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH) was featured in a recent article published by IT Brew, which delivers the latest news and analysis of trends shaping the IT industry, from cybersecurity and big data to software development. The piece discusses the post work-from-home (“WFH”) era and workers returning to the office with enhanced security setups. “In other words: The same security safeguards that protected users as they began working from home are still in effect in office environments. Software-defined networks (‘SD-WANs’), for example, enforced access control at home, and they’ll likely find a role in the office, according to Brian Haugli, CEO at the cybersecurity and privacy firm SideChannel,” the article reads, further quoting Haugli on this trend. “Now, with the return to the office, people are seeing the value out of software-defined networking, over having hardware-defined networking.”

To view the full article, visit https://ibn.fm/XY5BS

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Cerberus Sentinel (NASDAQ: CISO), a Scottsdale, Arizona-based industry leader as a managed cybersecurity and compliance provider, today announced plans for a corporate rebrand and launch. Central to the rebranding is a change of the company name to CISO Global, Inc. and an update to its corporate logo. “CISO Global was founded to bring cybersecurity professionals together on a global basis,” said David Jemmett, CEO and founder of CISO Global. “We have assembled a world-class leadership team, and we have successfully brought together 16 organizations globally. It is time for our name to reflect who we are as an organization.”

To view the full press release, visit https://ibn.fm/T5ElZ

About Cerberus Cyber Sentinel Corporation

Cerberus Sentinel is a global industry leader as a managed cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.ciso.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

TAAT(R) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) has provided an overview of the company’s corporate developments for the last six months; that period covers the time since Michael Saxon, a 25-year veteran of the tobacco industry, was named CEO. The overview included the following: TAAT acquired the profitable distribution business ADCO Distributors Inc., an independent retail-focused business that has grown substantially to approximately C$90 million in revenues; the company has received three reorders from its London-based distributor, with the most recent reorder being the largest; and TAAT is in advanced conversations with distributors in three other European markets. The company also focused on its “home” market of Las Vegas, as well as San Diego, California, resulting in TAAT products being sold in more than 800 stores in Las Vegas and 500 locations in San Diego; TAAT also expanded its focus markets to include Texas, which included initial placements in all 34 Buc-ee’s locations in Texas. The Company announced the creation of a new subsidiary called Beyond Alternatives, which will begin to distribute other alternative products in growing categories. “These are exciting times for TAAT in the global tobacco industry, and I am very proud of what our team has achieved over the past six months; particularly the results we are seeing in our home market of Las Vegas,” said TAAT CEO Michael Saxon in the press release. “I’ve launched many tobacco brands in many markets for some of the largest players in the industry, and I am actively applying this experience to the commercialization of TAAT as a novel alternative to cigarettes for adult smokers who want to move on from tobacco and nicotine. We have also sought to establish a presence in settings where adult smokers tend to use tobacco products (e.g., smoking areas of performance venues, outdoor events such as festivals) so that we can engage consumers directly to gain trial. There are many exciting developments on the horizon for the year 2023, which I look forward to sharing as they occur.”

To view the full press release, visit https://ibn.fm/nbpHj

About TAAT Global Alternatives Inc.

TAAT develops, manufactures and distributes alternative products in categories such as tobacco, hemp, kratom and other emerging CPG segments. Its flagship product is a nicotine-free, tobacco-free combustible with a patent-pending base material formulation, sold in several thousand stores throughout the United States. TAAT has reported an estimated C$80-plus million in overall gross revenue annually and has an operations center in Nevada as well as a distribution center and multiple convenience stores in Ohio. For more information, please visit www.TAATGlobal.com.  

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands in the U.S. legal cannabis sector, is eliminating an estimated $10.5 million in debt. The company announced that its board of directors voted to approve the settlement of $10.475 million in debt related to arm’s length financing through the issuance of common shares at a price of $0.47 per share. According to the company, that pricing represents a premium of 370% to the company’s closing price per share on Dec. 20, 2022. Following the vote, RWBYF issued 22,440,467 common shares to creditors of the company, noting that all securities issued will be subject to a statutory hold period that expires four months and one day from the date of issuance. “We continue to strengthen our balance sheet and eliminate debt at favorable terms for the company,” said Red White & Bloom president and director Colby De Zen in the press release. “As evidenced by the tremendous progress already made this year on restructuring our balance sheet and expanding margin and the reach for our branded products, we are committed to growing our business, achieving our profitability goals, and building shareholder value.”

To view the full press release, visit https://ibn.fm/ePUHB

About Red White & Bloom Brands Inc.

Red White & Bloom is a multistate cannabis operator and house of premium brands in the U.S. legal cannabis sector. RWB is predominantly focusing its investments on the major U.S. markets, including Arizona, California, Florida, Massachusetts and Michigan. For more information about the company, please visit www.RedWhiteBloom.com. 

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• SMBs are increasingly vulnerable to cyberattacks, from attacks on internal customer and employee records to proprietary secrets, and, although there are no foolproof solutions, there are now affordable and proven ways for SMBs to significantly mitigate the risks
• SideChannel’s team of vCISOs (virtual-based Chief Information Security Officer) possess a combined 400-plus years of experience in cybersecurity, offering creative solutions in the form of a bespoke cybersecurity program perfectly sized for growing enterprises
• The global cybersecurity market was valued at $139.77 billion in 2021 and is expected to reach $155.83 billion in 2022

The rapid digitization of supply chains creates serious new security risks. According to predictions by Gartner, 45% of organizations worldwide will have experienced cyberattacks on their software supply chains by 2025. With 60% of the current workforce working remotely, organizations are more vulnerable to attacks. They recommend that security leaders look beyond traditional approaches to security monitoring, detection, and response, to manage wider risks (https://ibn.fm/JnH6G).

SideChannel (OTCQB: SDCH) is simplifying cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, has announced its acquisition of Summit Aircraft Skis, including the company’s design and manufacturing assets, unique patents and related intellectual property, from the Sandpoint, Idaho-based Summit Aircraft Corporation. Favored by Carbon Cub owners, Summit Aircraft Skis are also preferred by the owners of many other types of non-CubCrafters manufactured backcountry capable aircraft. The unique ski design enables pilots to quickly and easily configure their aircraft to fly to many remote and primitive areas otherwise inaccessible in winter when runways are not maintained. “We are very excited and pleased to welcome Summit’s customers and products into our family here in Yakima,” said Patrick Horgan, CubCrafters president and CEO. “It has been a joy for our team to work together with Mike Custard, Summit’s founder, to coordinate a smooth ski manufacturing transition. Adding Summit Skis to the CubCrafters product lineup allows us to better meet our customers’ needs and adds a new profit center. We see a great potential for growth with the Summit brand that we want to be a part of going forward.”

To view the full press release, visit https://ibn.fm/kX1XA

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, today announced that it will be presenting at the Biotech Showcase on Monday, Jan. 9, 2023. Tryp’s presentation is slated to begin at 11 a.m. PT at the Hilton San Francisco Union Square Hotel in San Francisco, California. Interested parties should visit https://ibn.fm/dEhHP to attend the event. In addition, Tryp’s CEO Jim Gilligan and CBO Peter Molloy will be in San Francisco from Jan. 8-11, 2023, during the 41st Annual J.P. Morgan Health Care Conference and will be available for meetings with investors as detailed in the announcement.

To view the full press release, visit https://ibn.fm/kxOvb

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit has been demonstrated, subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

iClick (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced the results of its annual general meeting of shareholders. At the meeting, which was held in Hong Kong on Dec. 20, 2022, the company’s shareholders approved and ratified the appointment of Tiezhu (David) Zhang as a director of iClick.

To view the full press release, visit https://ibn.fm/R3GcB

About iClick Interactive Asia Group Limited

Founded in 2009, iClick is a leading enterprise and marketing cloud platform in China. iClick’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced it is rewarding all shareholders of record a digital coupon (“NFT”) redeemable for a gift package of company products valued at over $179 to drive shareholder engagement and additional revenue potential. According to the announcement, shareholders of record will be able to redeem the coupon to try the product first-hand or trade it with other fans globally on Upstream to bring new potential customers into the community. “By incorporating Upstream’s Web3 digital coupons into our strategy, we aim to provide our shareholders with first-hand experience of our products, which we hope will convert them into proud customers and brand ambassadors, driving additional engagement, revenue and sales to our company,” said Jupiter Wellness CEO Brian John.

To view the full press release, visit https://ibn.fm/60UqC

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements and licensing royalties. For more information, visit the company’s website at www.JupiterWellness.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH), a provider of cybersecurity services and technology for emerging and middle market companies, reported on its fiscal year ended Sept. 30, 2022. Highlights of the report include revenue for the company reaching $4.8 million, a 71% increase over 2021, with vCISO revenue totaling $3.1 million, an increase of 93% over 2021. SideChannel’s recurring vCISO revenue reportedly increased by 562% and recurring software and services revenue increased by 367%. “Our 2022 performance demonstrates our continued strength and position in the market across both product and service delivery,” said SideChannel CEO Brian Haugli in the press release. “Our investments in sales and marketing, coupled with our expanding cybersecurity, privacy and risk management capabilities, have proven to be effective at acquiring new clients and retaining existing relationships.”

In addition, SideChannel CEO Brian Haugli, who previously served as a cyber security leader with the U.S. Department of Defense, was featured as an expert along with cyber security consultant Alana Staszcyszyn in a recent interview published by CBC News. The piece covers discussion regarding TikTok, which is owned by a Chinese company, and questions that are being raised as to whether the Chinese government might exploit the platform’s security issues. American lawmakers this week banned TikTok from U.S. government devices, and there is a proposal in the United States to ban it outright. “So, obviously, it’s a social media app that can be installed on Android or Apple phones and devices. I think that the primary issue with that is its ability to look at and see and store your location with GPS, the networks that you’re on, even be able to look at badge notifications,” Haugli said in responding to how concerned users should be about having the app on their devices. “So, if you get a message from a friend, your mom or someone else, it has the ability to read that because you granted those permissions to the TikTok application on your phone. And when you really kind of dig into all the permissions that are in there, I don’t think it’s something that most users are either aware of or willing to hand over to a company that’s owned and housed inside of China.”

To view the full press release and interview, visit https://ibn.fm/7Xzjc and https://ibn.fm/vKga9

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. Today Vistagen, together with Pherin Pharmaceuticals, a clinical-stage drug development company focused on the discovery and development of investigational pherine compounds for treatment of neuropsychiatric and neuroendocrine conditions, announced entry into a definitive agreement. Under the agreement, Vistagen will acquire Pherin for approximately 12.4 million shares of Vistagen common stock and a nominal amount of cash. “Our confidence in the potential role of pherine compounds in fundamentally shifting the treatment paradigm for individuals living with anxiety, depression and several other disorders with unmet need has never been stronger,” said Shawn Singh, chief executive officer of Vistagen. “This transaction not only allows Vistagen to secure unencumbered global rights to a multi-asset pherine product pipeline and all future value from ownership of the pipeline, but it also establishes Vistagen as the market leader in the development and commercialization of this innovative class of small molecule drug candidates across a wide range of therapeutic areas.”

To view the full press release, visit https://ibn.fm/mlCkP

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those that are currently available. Vistagen’s clinical-stage candidates are targeting multiple types of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DSG Global (OTCQB: DSGT) wholly owned subsidiary Vantage Tag Systems has released a “statement of optimism” after a year of strategic acquisitions and new-product development along with booking an eight-figure order. According to the statement, the golf cart and low-speed vehicle (“LSV”) market is projected to grow at a CAGR of 8.2%, reaching $14.4 billion by 2027. Four-wheeled vehicles with a maximum speed of around 25 mph, LSVs have typically been used on golf courses; however, they are now being used as neighborhood and delivery vehicles and their use is expanding at industrial parks, college and university campuses, security patrols, hotels, amusement parks, airports, stadiums and gated golf communities. Vantage Tag is well positioned in this space and anticipates being able to take full advantage of the exploding LSV market. “We analyzed the market and made sure we had assembled a comprehensive suite of products to capitalize on both the commercial and consumer demand for LSV’s.” said Vantage Tag System CEO Bob Silzer in the press release. “We made a strategic acquisition for an iconic consumer cart brand that none of the incumbents can offer and also deliveries are available upon request. We made significant investments in new-product development of our own integrated GPS Management-enabled fleet carts and will be debuting the truly revolutionary SR1 single-rider cart at the upcoming PGA show in Orlando that has been engineered from scratch to address the holy grail of the golf industry; pace of play.”

To view the full press release, visit https://ibn.fm/pKFCB

About DSG Global Inc.

DSG Global was founded more than 12 years ago by the team that was one of the original pioneers of the GPS Golf Fleet Management industry. The company has two distinct brands to deliver on the explosive opportunities in the low-speed vehicle (“LSV”) and high-speed vehidle (“HSV”) markets. Liteborne Motor Company will address the HSV market with the new Aurium sport electric vehicle, along with many other vehicles in the pipeline, including buses and commercial vehicles. The LSV market will be supported and expanded by the established Vantage Tag Systems brand building on the 12-year track record of innovation in the marketspace with a comprehensive product lineup of GPS Fleet Management integrated carts for golf operators to the legendary Shelby golf carts, multipassenger carts and Shelby e-bikes. For more information about the company, please visit www.DSGTGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to DSGT are available in the company’s newsroom at https://ibn.fm/DSGT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Gratomic (TSX.V: GRAT) (OTCQX: CBULF) (FRA: CB82), a multinational company with projects in Namibia, Brazil and Canada, announces that it has disposed of noncore assets in Namibia. In addition, the company was notified by the Namibian government that it qualified for a Valued Added Tax (“VAT”) refund from two previous VAT periods. Total proceeds from the disposal of noncore assets was NAD 3.20 million (CDN$251,178). The VAT refunds, which Gratomic anticipates receiving within the next two weeks, totaled NAD 3.15 million (CDN$247,253). That means that Gratomic expects to receive NAD 6.35 million (CDN$498,431) in the coming days.

To view the full press release, visit https://ibn.fm/iSXx7

About Gratomic Inc.  

Gratomic is a multinational company with projects in Namibia, Brazil and Canada. The company is focused on becoming a leading global graphite supplier and aims to secure a strong position in the electric vehicle (“EV”) battery supply chain. With the continued development of its flagship Aukam project and further exploration on its Capim Grosso property, Gratomic sets itself apart by seeking out unique top-quality assets around the world. True to its roots, the company will continue to explore graphite opportunities displaying potential for development. Gratomic ranked third place in the top-10 preforming mining stocks on the 2022 TSX Venture 50(TM). Large quantities of high-quality vein graphite have been shipped for testing to confirm its viability as an anode material. Gratomic is confident that the test results will provide a unique competitive advantage in its desired target markets. The company has formed a collaboration agreement with Forge Nano. With its patented Atomic Layer Deposition (“ALD”) rhis cooperation with Forge Nano is a key element to support Gratomic’s strategies toward the value-added phases of production of graphite for anode applications, namely micronization, spheronization and coating, making Gratomic graphite a preferred choice for use in lithium-ion batteries. For more information about the company, visit www.Gratomic.ca

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, is reporting on its second and third quarter of 2022. According to the company, the filing, which includes financial results along with operation highlights, brings Vivos current on SEC filings for NASDAQ stock market purposes. The reported stated that there have been no restatements of the June and September 2021 quarter results as a result of the company’s conclusions; consequently, Vivos is unable to make direct results comparisons between Q2 and Q3 2022 and the same quarters in 2021 because of the changes in application of the company’s revenue recognition policies between these periods. The report went on to observe that this inability would not continue in 2023 and that direct comparisons between 2023 and 2022 would be possible. “We are pleased to finally report our second and third quarter results and to have the revenue recognition review process behind us,” said Vivos chair and CEO Kirk Huntsman. “We are even more pleased that the net effect of this review is relatively minimal. While we continued to face some headwinds in 2022, we believe we have reacted prudently. We can now report that through a series of cost reduction initiatives, operational streamlining, and new revenue opportunities, we are moving towards our goal of achieving positive cash flow operations in the next 12 to 18 months.”

To view the full press release, visit https://ibn.fm/AREhp

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution. It has proven effective in the treatment of more than 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has entered into a definitive agreement with a single healthcare-focused U.S. institutional investor. The agreement is for a registered direct offering to include the purchase and sale of 1,714,286 shares of the company’s common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,571,429 shares of common stock at a purchase price per share (and accompanying warrant) of $3.50. According to the announcement, the warrants will have an exercise price of $3.50 per share, will be initially exercisable beginning six months following the date of issuance and will expire five years from the initial exercise date. The offering will total an estimated $6 million. The company anticipates the offering to close this week. ATNF plans to use the net proceeds for R&D and general corporate purposes, including the preparation of a marketing authorization application and legal expenses. Alliance Global Partners is acting as the sole placement agent for the offering.

To view the full press release, visit https://ibn.fm/LCGhf

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs that are seeking to address major unmet medical needs. The company’s focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH) was featured in a recent article published by Built in Boston, the online community for Boston startups and tech companies. The piece discusses SideChannel’s success in growing its revenue by 114% over the past year and its business strategy of renting chief information security officers(“CISOs”) to startups. “Worcester-based SideChannel’s mission is to give every company access to the benefits of having a CISO without the cost of a full-time hire. The cybersecurity company evaluates an organization’s needs and matches the business with a virtual chief information security officer (‘vCISO’) that has enterprise-level experience,” the article reads. Further quoting SideChannel’s founder and CEO Brian Haugli on the innovative approach, he states, “Knowing that mid-market firms do not have the financial resources of larger enterprises, what if I could make CISOs fractionally available to them? Even better, what if these virtual CISOs were once actually CISOs with enterprise experience?”

To view the full article, visit https://ibn.fm/Tqvoi

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multi-layered cybersecurity programs for its clients. Learn more at SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing aid space, today announced its entry into a memorandum of understanding (“MOU”) with NUHEARA Limited (ASX: NUH), a medical device and consumer electronics manufacturer listed on the Australian Stock Market. “We are excited to work with NUHEARA’s management team to build a strong partnership,” said InnerScope CEO and President Matthew Moore. “This partnership gives NUHEARA access to InnerScope’s distribution network. In addition, the partnership gives InnerScope the ability to integrate NUHEARA’s FDA-Cleared OTC Self-Fitting Hearing Aid Patent Technology (‘FDA-Cleared Self-Fitting Technology’) into InnerScope’s HearingAssist and iHEAR OTC Hearing Aid branded products (‘InnerScope’s brands of OTC Hearing Aid products’). Integrating the FDA-Cleared Self-Fitting Technology into InnerScope’s brands of OTC Hearing Aid products will provide InnerScope the ability to offer and market InnerScope OTC Hearing Aids as FDA-Cleared Self-Fitting Hearing Aids. In addition, we are equally excited to have NUHEARA give InnerScope status as the exclusive third-party distributor who can market and sell the HP Hearing PRO FDA-Cleared Self-Fitting OTC Hearing Aids through InnerScope’s distribution network. The HP brand is a well-known and respected brand, and we are proud to add the HP Hearing PRO powered by NUHEARA into InnerScope’s brands of OTC Hearing Aid products.”

To view the full press release, visit https://ibn.fm/r9Zup

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s hearing products and its B2C and B2B business model break through the persistent barriers that prevent access to effective and affordable hearing solutions. InnerScope’s recent acquisition of iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, gives the company access to over 40 patents and an R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced hearing products through Walmart and many other major retailers and pharmacy chains. InnerScope’s full line of hearing products is currently available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, CVS.com, RiteAid.com, BestBuy.com, Amazon.com, Fingerhut.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, Cardinal Health(TM) at-Home, Carewell.com, FSAStore.com , HSAStore.com, WellDeservedHealth.com, and Topco Associates, representing 1000s of stores. Coming soon: Wakefern Food Corp. / ShopRite / SpartanNash / VG’s Grocery / Family Fare / Martin’s Super Markets. More in-store and online hearing products will soon launch with major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

iClick Interactive (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, reported that its board of directors has received a preliminary nonbinding proposal to acquire the company. Dated Dec. 20, 2022, the proposal letter is from the following companies: Igomax Inc., a British Virgin Islands company wholly owned by Jian Tang, ICLK chair of the board, CEO and company cofounder; Bubinga Holdings Limited, a British Virgin Islands company wholly owned by Wing Hong Sammy Hsieh, a director and company cofounder; and Rise Chain Investment Limited, a British Virgin Islands company wholly owned by Huang Jianjun. The proposal includes acquiring all ICLK outstanding ordinary shares and American depositary shares, other than those already owned by the three companies, or the consortium, for $4.0672 per ADS in cash, or $0.81344 per ordinary share; the transaction is subject to terms and conditions outlined in the proposal letter. According to the announcement, the consortium beneficially owns ICLK ordinary shares representing approximately 63% of the aggregate voting power of the company. The announcement also noted that a special committee of the board will evaluate the proposed transaction. “The board cautions the company’s shareholders and others considering trading the company’s securities that the board has just received the proposal letter, and the special committee has not had an opportunity to carefully review or evaluate the proposal or make any decision with respect to the company’s response to the proposal,” the company stated in the press release. “There can be no assurance that any definitive offer will be made, that any definitive agreement will be executed relating to the proposed transaction, or that the proposed transaction or any other transaction will be approved or consummated.”

To view the full press release, visit https://ibn.fm/1Aj6i

About iClick Interactive Asia Group Limited

iClick is a leading enterprise and marketing cloud platform in China. The company’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information about the company, please visit www.iClick.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SPYR (OTCQB: SPYR), a diversified technology company developing products leveraging the Internet of Things (IoT) for consumer use and large-scale applications and industries, has entered into a settlement agreement and release with Berkshire Capital Management Co. Inc. and Joseph Fiore. The agreement outlines the cancellation of 36,272,684 total common shares, with Berkshire agreeing to cancel 33,831,508 common shares and Fiore agreeing to cancel 2,441,176. The cancellations were made in exchange for a release of claims of outstanding legal claims between the parties. “I am pleased to report the cancellation of these shares representing over 10% of our current issued and outstanding shares,” said SPYR CEO Timothy Matula in the press release. “The company entered into this agreement to resolve outstanding legal claims between it and Berkshire and Fiore. I am glad to have resolved the company’s claims in an informal matter that terminates Berkshire and Fiore’s beneficial ownership in these shares, and returns them to treasury.”

To view the full press release, visit https://ibn.fm/cqlu0

About SPYR Inc.

SPYR Technologies is a technology company focused on IoT, or the Internet of Things. Through its subsidiary GeoTraq business, SPYR develops and manufactures fully self-contained, ultra-small mobile IoT modules: Trackertracker-M modules for asset tracking and location-based services, and Sensorsensor-M modules used for remote monitoring. SPYR continues to identify and target acquisitions that will grow its footprint in the industry and expand the products it offers consumers, including companies developing artificial intelligence (“AI”) and smart-technology products. For more information about this company, visit https://ir.spyr.com.

NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles (“EV”), today announced an expanded partnership between its subsidiary U.S. Hybrid and Toyota Tsusho America Inc. To accelerate the use of zero-emission hydrogen in port drayage operations, the parties are commencing the second phase of collaboration under which U.S. Hybrid will retrofit a second Top Pick Stacker, replacing diesel engines and drive trains with a new hydrogen fuel cell system. “This collaboration is special for me because Ideanomics gets to help create a better life for communities next to ports, where too many people are still breathing air full of toxic diesel pollution,” said Robin Mackie, president of Ideanomics Mobility. “The work doesn’t stop here. U.S. Hybrid is ready to help more port drayage fleet operators transition to zero-emission without breaking the bank or disrupting duty cycles. Few companies do what we do, and even fewer have the same proven track record of safe, on-time vehicle and equipment conversion.”

To view the full press release, visit https://ibn.fm/Lt31Z

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: accelerating the commercial adoption of electric vehicles. By bringing together vehicles, charging and financing solutions under one roof, Ideanomics is the one-stop partner needed to simplify the transition to and operation of any EV fleet. For more information about the company, visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has been awarded a $17.85 million order from the U.S. Department of Energy (“DOE”) – National Nuclear Security Administration (“NNSA”) to supply 300,000 pounds of U.S.-origin uranium concentrates at $59.50 per pound. UEC was awarded the order after responding to the NNSA’s Request for Proposals (“RFP”) to establish its strategic national Uranium Reserve program. U.S. officials have called the Uranium Reserve an important step in helping to rebuild America’s nuclear fuel capabilities and revitalizing U.S. capability to fuel its existing reactor fleet as well as new advanced reactors. The Uranium Reserve was originally designed as a 10-year, $1.5 billion plan to help revitalize the domestic uranium and conversion industry. UEC’s award is part of an initial $75 million authorized by Congress in 2020 to advance the government’s goal of supporting America’s nuclear fuel supply chain and capabilities. According to the announcement, UEC plans to deliver the order via book transfer in Q1 2023. “We are honored and delighted to be selected as a domestic producer for this purchase of uranium concentrates by the NNSA and look forward to the further expansion of the Uranium Reserve program in the coming years,” said Uranium Energy president and CEO Amir Adnani in the press release. “The U.S. nuclear reactor fleet that provides about 20% of America’s electricity production, and over half of its clean energy, imports nearly 60% of its current uranium requirements from Russia , Kazakhstan and Uzbekistan . The U.S. overdependence on these imports creates untenable energy and national security risks that need immediate high-priority attention from industry and the federal government.”

To view the full press release, visit https://ibn.fm/5r6Vr

About Uranium Energy Corp.

Uranium Energy Corp is the fastest-growing supplier of the fuel required for green-energy transition to a low-carbon future. UEC is the largest, diversified North American-focused uranium company, advancing the next generation of low-cost, environmentally friendly in-situ recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms in south Texas and Wyoming, anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, UEC has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American-warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource-stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, is reporting its unaudited financial results for the six months ended June 30, 2022. Highlights of the report for the first half of 2022 include total revenue of an estimated $778,000, a decrease of 43.7% compared to the same period of 2021, and gross profit margin for the same period of 64.9%, up from 61.4% for the same period of 2021. The report also noted that the average selling price of CDA-based tests was $36.8) for the six-month period, down 50.9% from the same period in 2021; the company noted that the decrease was primarily due to focusing on more conventional cancer detection tests at lower prices. Net loss for the first half of 2022 was an estimated $7.3 million, a 15.4% decrease from the same period in 2021; the company attributed the change to selling and marketing expenses, R&D expenses, general and administrative expenses, and impairment of intangible assets and good will. The report also noted non-GAAP net loss of approximately $6.6 million, an increase of 18.6% compared with the same period of 2021. Business highlights from the report included continued validation regarding the efficacy of CDA testing through clinical study follow-ups and progress on patent development: As of June 30, 2022, AnPac had filed 260 patent applications globally, with 155 patents being granted, including 22 patents granted in the United States, 68 in greater China (including eight in Taiwan), and 65 in other countries and regions. The company is continuing to build its cancer-risk assessment database, which currently includes  some 270,361 samples. AnPac also delivered an aggregate of 8,074,594 shares reserved for convertible debentures in principal balance of approximately $3.5 million by June 30, 2022, at conversion prices ranging from $0.16 to $1 per share. The company also issued 6 million shares as reserve for potential convertible loans conversion in the first quarter of 2022. “The first half year of 2022 was challenging due to COVID-19, especially in Shanghai area between early March to early May 2022, which affected our business and resulted in reduced paid cancer tests and hence revenue,” said AnPac Bio co-CEO Dr. Chris Yu in the press release. “However, we had a very strong June 2022 in paid cancer tests. We have also made significant efforts in reducing our costs including head counts, which has been effective and resulted in our reduced loss. We continue to advance our CDA technology in a number of areas including our multiyear follow-up study in enrolled individuals who had CDA tests. We reported multiyear clinical trial results in our CDA technology for lung cancer treatment prognosis in April’s American Association for Cancer Research conference. . . . In addition, due to our strong cost-reduction efforts in the first half of year, we expect that our costs will continue to reduce and loss will further narrow.”

To view the full press release, visit https://ibn.fm/0yxAC

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of June 30, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. According to a report by Frost & Sullivan, AnPac Bio ranked first globally in multicancer screening and detection-test sample volume, accumulative to January 2021. AnPac Bio’s CDA technology platform has been shown in retrospective validation studies to be able to detect the risk of more than 20 different cancer types with high sensitivity and specificity. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Small to medium-sized businesses (“SMBs”) face potentially prohibitive costs when it comes to hiring full-time cybersecurity experts 
• Despite the costs concern, the need is growing, as malicious computer experts often turn to SMBs and organizations as easy prey because of the smaller companies’ lack of experience, budget, and infrastructure necessary to ward off computer network invasions
• A San Diego school district recently reported its employees’ personal data was compromised in a cyberattack, and a Los Angeles school district reported it received a ransom demand after its computer files were seized in September and then published on the dark web
• SideChannel Inc. is helping SMBs to bridge the cybersecurity cost divide by offering virtual chief information security officers (“vCISOs”) as a contracted service that is more affordable than an in-house employee

When the San Diego Unified School District acknowledged recently that the personal information of many current and former employees was taken by unknown actors in a cybersecurity incident, it established that potentially malicious individuals have turned to public school systems in the latest reports of computer breaches.

NBC affiliate KNSD reported that prior to the incident in San Diego, a number of cybersecurity incidents involving schools and health care systems had been reported in California, including an attack on The Los Angeles Unified School District in September that locked up the district’s files and demanded a…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Cerberus Sentinel (NASDAQ: CISO) is an industry leader as a managed cybersecurity and compliance provider based in Scottsdale, Arizona. This positions the company in a rapidly growing sector, with Cybersecurity Ventures projecting that cybercrime damages will cost the world a whopping $8 trillion in 2023 in an expected upward trend. “We predict that global cybercrime damage costs will grow by 15% per year over the next three years, reaching $10.5 trillion USD annually by 2025, up from $3 trillion USD in 2015,” reads a recent article published by Cybersecurity Ventures. “The 2022 Official Cybercrime Report published by Cybersecurity Ventures and sponsored by eSentire, provides cyber economic facts, figures, predictions and statistics, which convey the magnitude of the cyber threat we are up against, and market data to help understand what can be done about it.”

To view the full article, visit https://ibn.fm/CByE0

About Cerberus Cyber Sentinel Corporation

Cerberus Sentinel is an industry leader as a managed cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CerberusSentinel.com.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Uranium Energy (NYSE American: UEC), the fastest growing supplier of the fuel for green energy transition to a low carbon future, today reported, in accordance with NYSE American requirements, the filing of the company’s quarterly report on Form 10-Q for the quarter ended Oct. 31, 2022, with the U.S. Securities and Exchange Commission (the “SEC”). The Form 10-Q filing, which includes UEC’s interim condensed consolidated financial statements, related notes and management’s discussion and analysis, is available for viewing on the SEC’s website or the company’s website. “This most recent quarter validates UEC’s growth strategy and our strengths and unique abilities as a pure-play, 100% unhedged uranium supplier,” said the company’s CEO and President Amir Adnani. “Supported by our strong balance sheet and physical portfolio, we are advancing a two-pronged approach, combining best in-class: 1) U.S. in-situ recovery (‘ISR’) production anchored by two processing plants; and 2) Canadian high-grade conventional development pipeline. The company’s North American warehoused physical portfolio is enabling opportunistic and profitable spot market sales and will be a reliable long-term source of supply.”

To view the full press release, visit https://ibn.fm/QXNC4

About Uranium Energy Corp.

Uranium Energy is the fastest growing supplier of the fuel for the green energy transition to a low carbon future. UEC is the largest, diversified North American-focused uranium company, advancing the next generation of low-cost, environmentally friendly in-situ recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub and spoke platforms in South Texas and Wyoming. These two production platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, the company has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about UEC, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting the publication of a new study in “Frontiers in Physiology,” a peer-reviewed journal; the study shows the effectiveness DRIO’s musculoskeletal solution, which uses real-time biofeedback and behavior training to reduce back pain. According to the announcement, the study evaluated retrospective data from 981 individuals who used Dario Move’s posture trainer for at least eight weeks, focusing on the relationship between the amount of time spent training, the use of the device and reduction in back-pain levels. Results indicated that, on average, users reported a 50% reduction in pain, with 60% of users reporting clinically important pain reduction after four weeks of biofeedback training; that number increased to 76% of users showing some pain reduction after eight weeks. Dario’s Move posture training solution involves a wearable biofeedback device and real-time data feedback. The device is designed to vibrate when the user slouches, which develops awareness and encourages proper posture. “Addressing chronic pain with posture training is known to have a positive impact on pain, and now we are able to better define that relationship and the role of the device,” said Dario vice president of clinical and scientific affairs Yifat Hershcovitz, PhD. “We are thrilled to demonstrate our ability to use real-time data from the sensor to drive healthier musculoskeletal health behaviors through ongoing training is now positively linked clinical outcomes.”

To view the full press release, visit https://ibn.fm/UzHlA

About DarioHealth Corp.

DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced that SRM Entertainment has filed a registration statement with the Securities and Exchange Commission to separate the company. Upon completion of the spinoff, SRM and Jupiter Wellness will operate as two independent and separate public companies, with Jupiter Wellness expected to remain the majority shareholder of SRM. “SRM is a nuts-and-bolts business; the more capital we have to turn, the faster we will grow,” said SRM CEO Richard Miller. “This IPO of SRM to the NASDAQ will provide us with the capital to continue our revenue growth while giving loyal Jupiter Wellness shareholders a stock dividend in SRM Entertainment.”

To view the full press release, visit https://ibn.fm/lJ0hw

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements and licensing royalties. For more information, visit the company’s website at www.JupiterWellness.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli authored an article for the Cyber Defense magazine. The piece, titled “Micro-Segmentation: Where Does It Fit into Zero Trust?”, discusses a zero trust, a recent buzzword that is a concept not a technology, Haugli explained. He also notes that zero trust is not micro-segmentation, and he cautions companies not to be misled by vendors that tout that an implementation of a micro-segmentation solution equates to having a zero trust environment. Zero trust, says Haugli, “is a strategic initiative to create least privilege across all aspects of an organization. It requires the three elements of the triad in any program: people, process and technology. You generally need an inventory of the users in the environment, the applications in place and the supporting infrastructure.  Without that inventory, a move towards zero rrust will be impossible.” He also goes on to observe that the basic requirement of micro-segmentation is expressly allow traffic from a source to a destination and deny all other traffic. “It’s one thing to build a program based on standards, but we must factor in the threats that are present that the program is built to reduce or stop,” wrote SideChannel CEO Brian Haugli in the article. “Cyber isn’t just addressing the defensive needs or accounting for the offensive threats. Ransomware is prevalent in our society today and an all-too-common news story both locally and nationally.  When we look at why it’s so destructive, it’s not the encryption of one system that causes the pain, it is that the impact is across so many systems. This is allowed to happen from flat networks or lack of segmentation between work groups.  A properly implemented micro-segmentation technology coupled with a strong managed policy would significantly reduce or even stop ransomware’s lateral movement across an environment. . . . The first question to answer is whether you have a cyber program built to a standard, such as NIST CSF. Then it’s onto how your organization meeting is each of the applicable controls.  As you define your remediations and mitigations, a micro-segmentation solution should make its way into your plan to address identified gaps in controls.  These are your first steps in the march towards zero trust.”

To view the full article, visit https://ibn.fm/GrMC3

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• With high-profile hacks abounding in 2022, Gartner forecasts that by 2025, 80% of enterprises will have adopted a strategy to unify web, cloud services, and private application access from a single vendor’s SSE platform
• Data443 Risk Mitigation offers a comprehensive and diverse software-as-a-service portfolio for data protection that is trusted by some of the world’s biggest companies
• During the first nine months of 2022, Data443 reported $2.3 million in revenue and $2.7 million in deferred revenue as it transitions customers from a one-time payment model into a recurring revenue model

As 2022 winds down, another year of lessons about data protection is in the books, alongside a year’s worth of notable breaches that made cybercriminals rich while costing economies and businesses billions of dollars. Teenage hacker group Lapsus bursts on the scene, hacking some of the world’s biggest companies, including Microsoft and Samsung. Vice Society hacked the U.S.’s second-biggest school district. Crypto video game company Axie Infinity was pillaged by cybercriminals to the tune of $620 million. Even hackers weren’t safe. Nefarious ransomware group Conti was penetrated by Ukrainian “hacktivists” that released internal content showing how they conduct their criminal enterprise.

2023 will likely be distinguished by a growing number of approaches using consolidated cybersecurity architecture and multi-layer approaches to protect against criminals who are notoriously adept at prying their way through any weakness, like a sentinel in the Matrix. Through strategic acquisitions…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, is releasing an update on its delay in filing required annual financial statements, management’s discussion and analysis, and related certifications for the fiscal year ended March 31, 2022; the update also included the filing status of its financial statements, management’s discussion and analysis, and related officer certifications for the three-month period ended June 30, 2022 as well as filing the required documents for the six-month period ended Sept. 30, 2022. According to the announcement, PLTXF’s 2022 audit is ongoing but has been delayed because the company has had to complete and restate its fiscal year required documents for March 31, 2021; the company is also implementing internal control procedures as a result of the restatement process. “Trading in the company’s securities currently remains subject to a general ‘failure to file’ cease trade order issued on Oct. 18, 2022, by the British Columbia Securities Commission,” the company stated in the announcement. “The company is working diligently with the auditors to complete and file the annual filings and the interim filings and expects to have the audit of the annual filings completed, and the annual filings filed, within a few business days. The company expects the interim filings to be filed concurrently with or shortly after the filing of the annual filings. The company is currently not subject to any insolvency proceedings and there is no other material information concerning the affairs of the company that has not generally been disclosed.”

To view the full press release, visit https://ibn.fm/NzTRR

About PlantX Life Inc.

PlantX is committed to being the digital face of the plant-based community as well as the one-stop shop for everything plant based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand. But the business is not limited to an ecommerce platform. PLTXF uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

CubCrafters, a best-in-class backcountry aircraft producer, is leveraging the anticipated growth of the light and ultralight aircraft market. The sector is projected to grow from $7.5 billion in 2022 to $11.9 billion in 2030, driven by the increasing number of backcountry enthusiasts. “‘Light aircraft’ is classified as any aircraft with a maximum gross takeoff weight of 12,500 pounds or less and most commonly used for general aviation purposes,” a recent article explains. “The company focuses on four main product lines – the Carbon Cub FX, NXCub, XCub, and Carbon Cub EX kits. The models are built to be lightweight and powerful, with some emphasizing short takeoff and landing capabilities and others built for longer missions in unforgiving backcountry environments. Dominating this sector, the company has developed seven models that emphasize flexibility, including varied landing gear configurations such as nosewheel, tailwheel, floats, and skis… In August, the company debuted a new lightweight engine for its Carbon Cub model, improving the CC340 that made previously unheard-of short takeoff and landing performance possible for backcountry enthusiasts. The new CC363i F/P is a higher displacement fuel-injected engine with more horsepower than the CC340, according to CubCrafters.”

To view the full article, visit https://ibn.fm/lvP3s

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) today announced that it released a new and updated version of lqwd.tech, the company’s proprietary, non-custodial Lightning Network (“LN”) software-as-a-service (“SaaS”) platform. The platform is designed for institutions, businesses and users to easily integrate and utilize the Lightning Network, which allows for millions of Bitcoin transactions to be made in seconds. “We are very excited for the release of the updated version of our Lightning Network platform, lqwd.tech,” said the company’s CEO Shone Anstey. “We have learned a lot and made vast improvements to the platform, and LQwD as a company has become a key player on the Lightning Network through its global routing nodes and our easy to use platform.”

To view the full press release, visit https://ibn.fm/3xbFr

About LQwD FinTech Corp.

LQwD is a Lightning Network Service Provider (“LSP”) focused on developing payment infrastructure and solutions accelerating the global mega trend of Bitcoin adoption through the Lightning Network. The company’s mission is to develop institutional grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility and scaling Bitcoin. LQwD also holds Bitcoin that is used as an operating asset, establishing nodes and payment channels on the Lightning Network.

NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced an end-of-the-year update to provide an overview of all current operations within the business, including several new developments. After one of its most challenging years, GTV management has refocused priorities intended to set the course for a promising outlook into 2023 and beyond. “This year has been one of the most valuable years our company has ever faced. Our focus and priority is to execute and deliver countless energy contracts that are believed to provide our company with a strong financial opportunity upon completion,” said Steffan Dalsgaard, CEO of Golden Triangle Ventures. “While navigating through one of the biggest opportunities of our lifetime, we are confident in our ability to deliver a success within our energy endeavors. Following this, we are excited to build out The Wellness Club with Dr. Dan Jurgens and prove a business model that we aim to develop into a highly profitable business. In addition, we have been actively working on a plan throughout this past year to develop a Luxury Real Estate business that aims to bolster several of the divisions within GTV. OTC Markets is currently in review of our recently submitted application in order to get current in our reporting obligations and the company has been actively preparing for its anticipated audit and expansion plans. With countless opportunities that are all being strategically implemented within the best of our ability, we are greatly looking forward to 2023 as I believe the stage is now being set to deliver fundamental growth, substantial accomplishments, and true value to all of our shareholders in the year ahead.”

To view the full press release, visit https://ibn.fm/ekLw1

About Golden Triangle Ventures Inc. (“GTV”)

Golden Triangle Ventures is a multifaceted consulting company pursuing ventures in the health, entertainment, technology, fulfillment, and food and beverage industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can assist and help develop into unique opportunities. Additionally, GTV provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion for and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://ibn.fm/GTVH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork